syndrome	score	normalized_score
DRAVET SYNDROME	3.0613516999999995	100.0
CHILDHOOD ABSENCE EPILEPSY	1.64574085	53.7586338087192
MYOCLONIC-ASTASTIC EPILEPSY	1.2192351539999997	39.826693352482174
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	38.99238365849961
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1528726900000001	37.658942943406345
CRANIO-CERVICAL DYSTONIA WITH LARYNGEAL AND UPPER-LIMB INVOLVEMENT	1.1455937999999999	37.42117575056796
SPINOCEREBELLAR ATAXIA TYPE 20	1.1227388999999999	36.674613374216364
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	32.665309248852395
UROFACIAL SYNDROME	1.0	32.665309248852395
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	32.665309248852395
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	30.6364355327093
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.784127	25.613750945374886
LAFORA DISEASE	0.77152896	25.202232072845476
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	25.172445883953813
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7485789639999999	24.452563356245545
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.7385356139999999	24.124494222601083
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	23.150849149413315
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.5961778400000001	19.474333510912846
ROLANDIC EPILEPSY	0.5906213	19.29282741345923
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	17.4214873776182
TREMOR, HEREDITARY ESSENTIAL, 5; ETM5	0.5324612000000001	17.393009761015048
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	17.215499937494936
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.520283494	16.99522122858344
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.512173454	16.730304263962882
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	16.63511121574173
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	16.56269189848393
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.5018434030000001	16.392869953491466
PAROXYSMAL HEMICRANIA	0.5	16.332654624426198
CREST SYNDROME	0.5	16.332654624426198
INHALATIONAL ANTHRAX	0.5	16.332654624426198
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	16.332654624426198
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	16.332654624426198
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728000000003	13.768338998750131
SPINOCEREBELLAR ATAXIA TYPE 10	0.42051920000000004	13.736389713080014
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415887734	13.585101443914466
PERIORAL MYOCLONIA WITH ABSENCES	0.39904270999999997	13.034853525650124
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.38836981000000004	12.68621994656805
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.36781579999999997	12.014816853614043
SPINOCEREBELLAR ATAXIA TYPE 12	0.3657942	11.948780664436566
POSTENCEPHALITIC PARKINSONISM	0.362445819	11.839404763588583
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	11.678424925826066
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	11.678424925826066
CENTRALOPATHIC EPILEPSY	0.35470090000000004	11.586414589346273
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.3484563639999999	11.382434889790675
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.346047873	11.303760786452601
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.28171108206875
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	11.263890391946802
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34381168	11.230714850567482
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34259226	11.190882119163245
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.337901203	11.037647291554253
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.33676943	11.00067757650975
COG4-CDG	0.33463498399999997	10.930955237844774
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.333874419	10.906111146915922
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.333874419	10.906111146915922
CLEFT LIP AND ALVEOLUS	0.333333	10.888425527847717
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	10.888425527847717
SCHIZOPHRENIA 10	0.333333	10.888425527847717
SPINOCEREBELLAR ATAXIA TYPE 25	0.333333	10.888425527847717
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.333333	10.888425527847717
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	10.888425527847717
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31642234	10.33603358934552
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.301281414	9.84145055924153
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.275267114	8.991685404849107
LENNOX-GASTAUT SYNDROME	0.26705410999999996	8.723405089327045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.26676428399999996	8.713937833408687
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	8.350231500679914
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.254026784	8.297863456851431
PALLISTER-HALL SYNDROME	0.250545554	8.184148002335048
HYPERPARATHYROIDISM 2	0.25	8.166327312213099
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	8.166327312213099
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	8.166327312213099
DYSTONIA 6, TORSION	0.25	8.166327312213099
HYPEREKPLEXIA 1; HKPX1	0.25	8.166327312213099
SPINOCEREBELLAR ATAXIA TYPE 18	0.24545450000000002	8.017847149022442
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.24545450000000002	8.017847149022442
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	7.939145116844958
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.23779343000000003	7.7675959282953375
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	7.663765127018893
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	7.380045553080363
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.22222199999999998	7.258950351898477
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.217603494	7.108085425140798
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.212929884	6.95542050918227
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.212796284	6.951056423866622
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.20704225	6.763099123828212
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20688471	6.757953031009147
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	6.702539273746301
SPINOCEREBELLAR ATAXIA TYPE 13	0.201086973	6.568568158960633
ANGELMAN SYNDROME	0.201086973	6.568568158960633
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.20054555400000001	6.550882539892429
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.20054555400000001	6.550882539892429
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.53306184977048
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.19789361	6.46425596902179
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175000000003	6.186540082931343
SPINOCEREBELLAR ATAXIA TYPE 42	0.1851369	6.047554091873861
JUVENILE MYOCLONIC EPILEPSY	0.1829753	5.976944759401543
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	5.921757176739936
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	5.921757176739936
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17118598399999999	5.591843106429098
UNILATERAL POLYMICROGYRIA	0.16875813	5.512536504708035
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.210303017454676
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.210303017454676
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15677133	5.120983975803891
SPINOCEREBELLAR ATAXIA TYPE 28	0.1565655	5.1142604752012
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.1565655	5.1142604752012
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	4.986745364800784
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	4.986745364800784
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	4.951783226997408
PRIMARY DYSTONIA, DYT13 TYPE	0.1458333	4.763689843280667
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14432753999999998	4.714503727226114
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.144158984	4.708997793360365
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.6664680833633065
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.6664680833633065
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13754538400000002	4.492962504112156
DYSTONIA 16; DYT16	0.13539257999999998	4.422640495699988
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.327457704385942
SPINOCEREBELLAR ATAXIA TYPE 2	0.1319443	4.310001363123355
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.12843643	4.195415704768584
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.12843643	4.195415704768584
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.126301984	4.125693366103608
HUNTINGTON DISEASE-LIKE 1	0.125541419	4.100849275174754
OCULAR MOTOR APRAXIA	0.125	4.083163656106549
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.12336172999999999	4.029649059923432
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.1231672	4.023294677315254
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.12315085399999999	4.022760730170271
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12144438000000002	3.967018229235146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	3.949752457386716
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	3.8773331401289175
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	3.8595124500069695
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.11455927999999999	3.7421143085258715
PRIMARY DYSTONIA, DYT4 TYPE	0.11455927999999999	3.7421143085258715
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	3.6942929490917367
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.112954403	3.6896905050145015
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.112954403	3.6896905050145015
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.112954403	3.6896905050145015
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.112412984	3.6720048859462966
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.112412984	3.6720048859462966
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.11240884899999999	3.6718698148925526
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.11219797299999999	3.664981485139392
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.11165655399999999	3.6472958660711874
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.11165241899999999	3.647160795017443
PRIMARY DYSTONIA, DYT27 TYPE	0.11111099999999999	3.6294751759492385
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.11111099999999999	3.6294751759492385
COMPLEX REGIONAL PAIN SYNDROME	0.11111099999999999	3.6294751759492385
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.11111099999999999	3.6294751759492385
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.11111099999999999	3.6294751759492385
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.11111099999999999	3.6294751759492385
BRUNNER SYNDROME; BRNRS	0.11111099999999999	3.6294751759492385
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.11111099999999999	3.6294751759492385
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.11111099999999999	3.6294751759492385
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.11111099999999999	3.6294751759492385
SPINOCEREBELLAR ATAXIA 12	0.10795450000000001	3.526367127305237
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.487311307616176
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.10525655	3.4382377562172954
BILATERAL POLYMICROGYRIA	0.104660764	3.4187762222811586
AICARDI SYNDROME; AIC	0.10444313000000001	3.4116671403680936
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.10362397300000001	3.3849091236397317
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.102537	3.3494028144495784
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.10187508400000002	3.3277811236128154
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.101857573	3.3272091213825585
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.1017026	3.3221468804123364
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0992976	3.2435868116688464
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.099150284	3.2387746889715423
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.099150284	3.2387746889715423
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.232333743293854
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.205180574319508
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.205180574319508
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.205180574319508
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.205180574319508
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.205180574319508
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09708065000000002	3.171169454329603
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.096586434	3.155025735853872
PELIZAEUS-MERZBACHER DISEASE	0.09618893300000002	3.1420412427621445
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.09199607300000001	3.005080174225001
PONTINE TEGMENTAL CAP DYSPLASIA	0.09199607300000001	3.005080174225001
SPINOCEREBELLAR ATAXIA TYPE 36	0.09156520000000001	2.99100557443302
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.09145465400000001	2.987394555156796
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.09145051900000001	2.9872594841030526
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.0909091	2.9695738650348478
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08856235400000001	2.8929166812163407
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.5819578325482833
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.5305375400023467
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.5305375400023467
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.5127168498803982
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.5127168498803982
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.076744873	2.506895009808903
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.4926603500016027
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0740259	2.418078915924623
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.07299053	2.3842582346876386
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.3510579983345274
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.3510579983345274
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.3365561036322617
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.333237308212579
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.333237308212579
SCHINZEL-GIEDION SYNDROME	0.07142860000000001	2.333237308212579
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.3120309894482234
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.0694982	2.2701801952385936
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.243900953947892
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.220083011043782
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.2023973919755777
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.195509062222417
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.177688372100468
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.177688372100468
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.177688372100468
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.177688372100468
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.177688372100468
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.177688372100468
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.177688372100468
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.177688372100468
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.177688372100468
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.177688372100468
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.177688372100468
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.177688372100468
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.06628780000000001	2.165311486426078
SPINOCEREBELLAR ATAXIA 27; SCA27	0.06628780000000001	2.165311486426078
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06590177300000001	2.1527017950926717
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.117195485902519
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.06434340300000001	2.1017971571185377
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.064030564	2.0915781744384354
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.06325643	2.066290847928385
X-LINKED DYSTONIA-PARKINSONISM	0.0630542	2.0596849424389894
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0630542	2.0596849424389894
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.063041419	2.0592674471214796
DILATED CARDIOMYOPATHY WITH ATAXIA	0.063041419	2.0592674471214796
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.062953104	2.0563826103351666
UROCANIC ACIDURIA	0.0625	2.0415818280532747
CARIBBEAN PARKINSONISM	0.0625	2.0415818280532747
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0625	2.0415818280532747
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.0625	2.0415818280532747
HUNTINGTON DISEASE-LIKE 2	0.0625	2.0415818280532747
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0625	2.0415818280532747
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.06103259999999999	1.9936487532615086
DISTAL MONOSOMY 12Q	0.05885138399999999	1.922398658082964
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	1.8873332979023616
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.057082400000000005	1.8646142486666923
WHITE-SUTTON SYNDROME; WHSUS	0.056857584	1.8572705645026024
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.8147408545055446
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.8147408545055446
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.8147408545055446
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.8147408545055446
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8147408545055446
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.8147408545055446
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.8147408545055446
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.8147408545055446
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	1.8147408545055446
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.8147408545055446
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.8147408545055446
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.8147408545055446
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8147408545055446
GITELMAN SYNDROME	0.055555600000000004	1.8147408545055446
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.8147408545055446
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	1.8147408545055446
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0553161	1.8069175129404442
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.0553161	1.8069175129404442
TREMOR, HEREDITARY ESSENTIAL, 1	0.0553161	1.8069175129404442
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037643999999994	1.6998257338416884
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.6718470798373155
TRICHOTHIODYSTROPHY	0.049966884	1.632183718061535
X-LINKED CENTRONUCLEAR MYOPATHY	0.049444199	1.6151100508967988
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.049404699999999996	1.6138198038467781
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.049404699999999996	1.6138198038467781
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.049404699999999996	1.6138198038467781
MULTIPLE SYSTEM ATROPHY	0.049404699999999996	1.6138198038467781
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.049404699999999996	1.6138198038467781
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.6031106128707788
DYSTONIA 23; DYT23	0.04890278	1.5974244318285942
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04889093	1.5970373479139952
MYOCLONUS AND ATAXIA	0.0486649	1.589654008064477
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0486649	1.589654008064477
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.5862146776536654
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.048182119	1.573883817400007
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0481814	1.573860331042657
BRAIN-LUNG-THYROID SYNDROME	0.047412684	1.5487499851781161
FRIEDREICH ATAXIA	0.046110700000000004	1.5062202751810585
MAN1B1-CDG	0.045541073	1.4876132330695624
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.0454545	1.4847852992519615
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0454545	1.4847852992519615
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0454545	1.4847852992519615
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0454545	1.4847852992519615
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0454545	1.4847852992519615
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.4675056773124109
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297954	1.447006366501438
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.447006366501438
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04326676399999999	1.4133222262571137
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.412733924037542
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042778383999999996	1.3973691425261594
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.3966559281640203
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.3949132339155936
COG2-CDG	0.04221225399999999	1.3788763310011065
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.04202758399999999	1.372844028342121
MERRF	0.041517359999999996	1.3561774035959346
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.040707684	1.329729086664561
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0401993	1.3131225660873924
SARCOSINEMIA	0.039845904	1.3015787764600848
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.03930035	1.2837580863381364
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.2837580863381364
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.2828352913518564
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.2583101771678178
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.038472499	1.2567160774111648
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.038460649	1.2563289934965658
16P13.11 MICRODELETION SYNDROME	0.038338984	1.2523547686468042
LISSENCEPHALY 2; LIS2	0.038338984	1.2523547686468042
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03825648	1.2496597499725368
DOORS SYNDROME	0.038096033999999994	1.2444187317647954
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.03793108	1.2390304583429603
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.03791923	1.2386433744283614
PROGRESSIVE SUPRANUCLEAR PALSY	0.03791923	1.2386433744283614
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.03791923	1.2386433744283614
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.03791923	1.2386433744283614
SPINOCEREBELLAR ATAXIA TYPE 37	0.03791923	1.2386433744283614
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.23746840325468
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.03779343	1.234534078524856
CHRISTIANSON SYNDROME	0.03779343	1.234534078524856
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03779343	1.234534078524856
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.2276457487716945
9P13 MICRODELETION SYNDROME	0.0372076	1.2153977604076005
CANAVAN DISEASE	0.037037	1.2098250586497463
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.2098250586497463
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2098250586497463
MCLEOD SYNDROME; MCLDS	0.037037	1.2098250586497463
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.037016284	1.2091483641033474
CHROMOSOME 1P36 DELETION SYNDROME	0.036826303	1.2029425759869408
MENTAL RETARDATION, X-LINKED 98; MRX98	0.036765933	1.2009705712675878
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.03642268	1.1897581058719913
ATYPICAL RETT SYNDROME	0.036280749	1.1851218858649926
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.036280749	1.1851218858649926
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03621180399999999	1.18286977611883
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	1.1799374113075607
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03573933	1.167436266796788
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.035671103999999995	1.1652076434079757
JUVENILE ABSENCE EPILEPSY	0.03566625	1.1650490859968818
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.1650490859968818
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.1650490859968818
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.035569773	1.1618976349564805
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.035528453999999994	1.160547937043627
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.035524319	1.160412865989883
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.035028354	1.144212015888276
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.035028354	1.144212015888276
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.035028354	1.144212015888276
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.035028354	1.144212015888276
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.035028354	1.144212015888276
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.035024219	1.144076944834532
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.1374077013105033
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03461480399999999	1.130703277248413
SPINAL MUSCULAR ATROPHY, TYPE II	0.0344828	1.1263913257663276
DYSTONIA 7, TORSION	0.0344828	1.1263913257663276
SPINAL MUSCULAR ATROPHY, TYPE III; SMA3	0.0344828	1.1263913257663276
PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK	0.0344828	1.1263913257663276
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.0344828	1.1263913257663276
GIANT AXONAL NEUROPATHY	0.0344828	1.1263913257663276
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.0344828	1.1263913257663276
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	1.1263913257663276
NORMAL PRESSURE HYDROCEPHALUS	0.0344828	1.1263913257663276
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0344828	1.1263913257663276
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.0344828	1.1263913257663276
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.0344828	1.1263913257663276
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.0344828	1.1263913257663276
SPINOCEREBELLAR ATAXIA TYPE 27	0.0344828	1.1263913257663276
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	1.1263913257663276
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	1.1263913257663276
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.0344828	1.1263913257663276
SPINAL MUSCULAR ATROPHY, TYPE IV	0.0344828	1.1263913257663276
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	1.1263913257663276
RICHIERI COSTA-DA SILVA SYNDROME	0.0344828	1.1263913257663276
BECKER MUSCULAR DYSTROPHY	0.0344828	1.1263913257663276
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.0344828	1.1263913257663276
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.0344828	1.1263913257663276
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.0344828	1.1263913257663276
WOLF-HIRSCHHORN SYNDROME	0.034101503	1.1139361413456677
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.034101503	1.1139361413456677
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.1128825871264645
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.1128825871264645
YOU-HOOVER-FONG SYNDROME; YHFS	0.033560084	1.0962505222774632
SLC35A2-CDG	0.033560084	1.0962505222774632
PEHO SYNDROME	0.033560084	1.0962505222774632
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.0962505222774632
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555949	1.0961154512237195
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.033555948999999995	1.0961154512237192
ISOLATED CEREBELLAR AGENESIS	0.033555948999999995	1.0961154512237192
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.033555948999999995	1.0961154512237192
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.0892271214705584
AICARDI SYNDROME	0.03301453	1.078429832155515
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.0715415024023538
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.0715415024023538
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.07140643134861
LEIGH SYNDROME	0.032799519	1.07140643134861
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.07140643134861
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.07140643134861
NEURONAL CEROID LIPOFUSCINOSIS	0.032799519	1.07140643134861
SANDHOFF DISEASE	0.032799519	1.07140643134861
TUBEROUS SCLEROSIS-1	0.032799519	1.07140643134861
FLYNN-AIRD SYNDROME	0.032799519	1.07140643134861
15Q13.3 MICRODELETION SYNDROME	0.032346003000000005	1.0565921909593077
HUNTINGTON DISEASE	0.0322581	1.0537208122804056
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.0537208122804056
WEST SYNDROME	0.0322581	1.0537208122804056
LESCH-NYHAN SYNDROME	0.0322581	1.0537208122804056
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0322581	1.0537208122804056
DIENCEPHALIC SYNDROME	0.0322581	1.0537208122804056
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.0537208122804056
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.0537208122804056
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.0537208122804056
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.0537208122804056
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.0537208122804056
ALG13-CDG	0.0322581	1.0537208122804056
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.03201968	1.0459327492492942
PARKINSON DISEASE, LATE-ONSET; PD	0.03200783	1.0455456653346953
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.03198251	1.0447185797045142
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.03132383	1.02320259380848
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.0200366720360814
3P25.3 MICRODELETION SYNDROME	0.031226909999999997	1.0200366720360814
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467402999999997	0.9952271410044132
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0303993	0.9930025354486388
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.029873384	0.9758233266697194
WAISMAN SYNDROME; WSMN	0.029658373000000002	0.9687999258628144
ATYPICAL JUVENILE PARKINSONISM	0.029112819	0.950979235740866
RAPID-ONSET DYSTONIA-PARKINSONISM	0.029112819	0.950979235740866
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.029112819	0.950979235740866
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.029112819	0.950979235740866
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.029112819	0.950979235740866
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.029079784	0.9499001372498301
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	0.9499001372498301
MENKES DISEASE	0.029075649000000002	0.9497650661960861
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	0.935011811939151
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.935011811939151
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.0285714	0.9332936166726615
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0285714	0.9332936166726615
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0285714	0.9332936166726615
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.0285714	0.9332936166726615
PARKINSONISM WITH SPASTICITY, X-LINKED	0.0285714	0.9332936166726615
PARKINSON DISEASE 23, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	0.9332936166726615
PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8	0.0285714	0.9332936166726615
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.0285714	0.9332936166726615
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	0.9320794471278817
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	0.9320794471278817
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.02853423	0.9320794471278817
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.02853423	0.9320794471278817
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	0.9257794195942923
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341363999999997	0.9257794195942923
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9251911173747207
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.028178494	0.9204592206769318
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.027783429999999998	0.9075543329438431
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9073704272527723
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9073704272527723
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9073704272527723
OROFACIAL CLEFT 3	0.027777800000000002	0.9073704272527723
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	0.9073704272527723
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9073704272527723
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9073704272527723
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9073704272527723
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9073704272527723
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	0.9073704272527723
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	0.9073704272527723
CLEFT CHIN	0.027777800000000002	0.9073704272527723
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.027777800000000002	0.9073704272527723
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9073704272527723
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9073704272527723
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9073704272527723
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	0.9073704272527723
MENINGIOMA	0.027777800000000002	0.9073704272527723
DIMPLES, FACIAL	0.027777800000000002	0.9073704272527723
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	0.9073704272527723
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9073704272527723
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9073704272527723
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9073704272527723
GANGLIOCYTOMA	0.027777800000000002	0.9073704272527723
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9073704272527723
DWARFISM, LEVI TYPE	0.027777800000000002	0.9073704272527723
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9073704272527723
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9073704272527723
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9073704272527723
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9073704272527723
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9006660031906822
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	0.9005309321369382
BENIGN OCCIPITAL EPILEPSY	0.027027	0.8828453130687338
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.8828453130687338
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.027027	0.8828453130687338
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.8828453130687338
CHROMOSOME 17Q12 DELETION SYNDROME	0.027027	0.8828453130687338
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.8828453130687338
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.0268565	0.8772758778418044
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.0253265	0.8272979546910604
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.02428158	0.7931653197507496
MANGANESE POISONING	0.02428158	0.7931653197507496
X SMALL RINGS	0.023470504	0.7666712713864272
SALT-AND-PEPPER SYNDROME	0.023274964	0.7602838968159066
XQ12-Q13.3 DUPLICATION SYNDROME	0.02317359	0.7569724837561135
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7354007708425008
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.7354007708425008
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.7354007708425008
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.022135283999999998	0.7230558971711745
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.7204511654116711
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02197298	0.7177541868188488
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7175800807205523
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.6953269694560086
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.0208333	0.6805261871741167
SPINOCEREBELLAR ATAXIA TYPE 1	0.0208333	0.6805261871741167
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0208333	0.6805261871741167
DYSTONIA, DOPA-RESPONSIVE; DRD	0.0208333	0.6805261871741167
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0208333	0.6805261871741167
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.0208333	0.6805261871741167
GILLESPIE SYNDROME; GLSP	0.0208333	0.6805261871741167
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.0208333	0.6805261871741167
SPINOCEREBELLAR ATAXIA 15	0.0208333	0.6805261871741167
PRIMARY PROGRESSIVE FREEZING GAIT	0.0208333	0.6805261871741167
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0208333	0.6805261871741167
DYSTONIA 27; DYT27	0.0208333	0.6805261871741167
DYSTONIA 16	0.0208333	0.6805261871741167
SPINOCEREBELLAR ATAXIA 20	0.0208333	0.6805261871741167
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0208333	0.6805261871741167
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0208333	0.6805261871741167
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0208333	0.6805261871741167
LEBER HEREDITARY OPTIC NEUROPATHY	0.0208333	0.6805261871741167
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.6775062793340603
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.6775062793340603
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.6775062793340603
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.020417234	0.6669352626161836
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.020406103000000002	0.6665716650589347
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019838533999999998	0.6480318481538727
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.01973794	0.6447459140352937
GAUCHER DISEASE	0.01973794	0.6447459140352937
AMISH INFANTILE EPILEPSY SYNDROME	0.019292979999999998	0.6302111580319243
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.6233228282787633
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.605502138156815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.018444729	0.6025027767962761
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.018437013999999998	0.6022507639354211
MYOCLONIC-ATONIC EPILEPSY	0.01836183	0.5997948553248554
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.017726103	0.5790286362720103
PHELAN-MCDERMID SYNDROME	0.017726103	0.5790286362720103
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.017725384	0.5790051499146603
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5631956628831638
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5631956628831638
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5631956628831638
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5631956628831638
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5631956628831638
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5631956628831638
ALCOHOL DEPENDENCE	0.0172414	0.5631956628831638
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5631956628831638
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5631956628831638
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5631956628831638
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5631956628831638
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5631956628831638
DIASTEMATOMYELIA	0.0172414	0.5631956628831638
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5631956628831638
CERVICAL RIB	0.0172414	0.5631956628831638
SICKLE CELL ANEMIA	0.0172414	0.5631956628831638
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5631956628831638
CARDIAC ARRHYTHMIA	0.0172414	0.5631956628831638
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5631956628831638
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5631956628831638
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5631956628831638
ERYTHERMALGIA, PRIMARY	0.0172414	0.5631956628831638
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5631956628831638
269800 SENILE PLAQUE FORMATION	0.0172414	0.5631956628831638
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5631956628831638
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5631956628831638
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5631956628831638
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5631956628831638
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5631956628831638
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5631956628831638
RHEUMATOID ARTHRITIS	0.0172414	0.5631956628831638
TRANSSEXUALITY	0.0172414	0.5631956628831638
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.5631956628831638
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5631956628831638
MOSAIC TRISOMY 15	0.0172414	0.5631956628831638
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5631956628831638
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.5631956628831638
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.5631956628831638
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5631956628831638
THUMBS, CONGENITAL CLASPED	0.0172414	0.5631956628831638
PALMOMENTAL REFLEX	0.0172414	0.5631956628831638
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5631956628831638
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5631956628831638
MOTION SICKNESS	0.0172414	0.5631956628831638
MYOPATHY, CONGENITAL	0.0172414	0.5631956628831638
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5631956628831638
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5631956628831638
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5631956628831638
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5631956628831638
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5631956628831638
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5631956628831638
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5631956628831638
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5631956628831638
DUPLICATION/INVERSION 15Q11	0.017180549	0.5612079461500619
CORNELIA DE LANGE SYNDROME 1	0.017180549	0.5612079461500619
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01714688	0.5601081378529622
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.01705794	0.5572028852483694
AYMÉ-GRIPP SYNDROME	0.016968953999999998	0.5542961300395509
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064	0.5503145554952082
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064	0.5503145554952082
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.016639130000000002	0.5435223270818575
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.016639130000000002	0.5435223270818575
OCULOFACIOCARDIODENTAL SYNDROME	0.016428254	0.5366339973286964
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.5324938653732598
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5324938653732598
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.5324938653732598
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.016232714	0.5302466227581758
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.016151303	0.5275873072669175
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0158827	0.518813307206748
HUNTER-MACDONALD SYNDROME	0.0158827	0.518813307206748
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0158827	0.518813307206748
BRACHYDACTYLY, TYPE A2; BDA2	0.0158827	0.518813307206748
SYNDACTYLY TYPE 5	0.0158827	0.518813307206748
BRACHYDACTYLY TYPE A7	0.0158827	0.518813307206748
SYNDACTYLY TYPE 2	0.0158827	0.518813307206748
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0158827	0.518813307206748
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.50536349678477
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.015470953999999999	0.50536349678477
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.50536349678477
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.50536349678477
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.50536349678477
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.50536349678477
HAREL-YOON SYNDROME; HAYOS	0.015470953999999999	0.50536349678477
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.50536349678477
SMITH-LEMLI-OPITZ SYNDROME	0.015001303	0.4900222016307373
RING CHROMOSOME 22 SYNDROME	0.015001303	0.4900222016307373
MYHRE SYNDROME	0.015001303	0.4900222016307373
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.015001303	0.4900222016307373
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.015000583999999999	0.4899987152733873
19P13.3 MICRODUPLICATION SYNDROME	0.015000583999999999	0.4899987152733873
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015000583999999999	0.4899987152733873
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01493073	0.487716912761118
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01493073	0.487716912761118
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.4875428066628215
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.4875428066628215
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.4875428066628215
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.4875428066628215
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.014894119	0.48652100312420826
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.014683390000000001	0.47963747517150684
WARSAW BREAKAGE SYNDROME; WABS	0.014459884	0.4723365825625328
ADAMS-OLIVER SYNDROME 3; AOS3	0.014459884	0.4723365825625328
TOWNES-BROCKS SYNDROME 1; TBS1	0.014459884	0.4723365825625328
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.014459884	0.4723365825625328
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.014459884	0.4723365825625328
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.014459884	0.4723365825625328
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.014455749	0.47220151150878886
ADNP SYNDROME	0.014455749	0.47220151150878886
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.014455749	0.47220151150878886
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014455749	0.47220151150878886
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.014455749	0.47220151150878886
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.014455749	0.47220151150878886
XP22.13P22.2 DUPLICATION SYNDROME	0.014455749	0.47220151150878886
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.014455029999999999	0.47217802515143886
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0143527	0.46883538405600383
SIALURIA	0.014244873	0.46531318175562786
MEND SYNDROME	0.014244873	0.46531318175562786
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.014244873	0.46531318175562786
MEND SYNDROME; MEND	0.014244873	0.46531318175562786
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.014244873	0.46531318175562786
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.014244873	0.46531318175562786
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.4652896953982778
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.4652896953982778
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.4652896953982778
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.4652896953982778
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.01391433	0.45451589244058443
FEINGOLD SYNDROME 1; FGLDS1	0.01391433	0.45451589244058443
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.01391433	0.45451589244058443
PSEUDOTRISOMY 13 SYNDROME	0.01391433	0.45451589244058443
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.013703454	0.4476275626874234
MEIER-GORLIN SYNDROME 7	0.013703454	0.4476275626874234
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.013699319	0.4474924916336794
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.013699319	0.4474924916336794
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.44746900527632943
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.44746900527632943
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.44746900527632943
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.44746900527632943
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.44746900527632943
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.44746900527632943
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.44746900527632943
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.013471303	0.44004427847999306
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.013471303	0.44004427847999306
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.013337703	0.4356801931643464
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.013286044	0.43399273595385995
KRABBE DISEASE	0.013253094	0.43291641401411024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.013241244	0.43252933009951133
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.013241244	0.43252933009951133
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0131579	0.429806872565475
CHROMOSOME 2Q35 DUPLICATION SYNDROME	0.0131579	0.429806872565475
JACKSON-WEISS SYNDROME	0.0131579	0.429806872565475
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.0131579	0.429806872565475
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0131579	0.429806872565475
%608572 BURN-MCKEOWN SYNDROME	0.0131579	0.429806872565475
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0131579	0.429806872565475
SYNDACTYLY, TYPE IV; SDTY4	0.0131579	0.429806872565475
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0131579	0.429806872565475
16P12.1P12.3 TRIPLICATION SYNDROME	0.0131579	0.429806872565475
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0131579	0.429806872565475
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.0131579	0.429806872565475
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.012929884	0.42235865941178874
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.012925749	0.4222235883580447
RING CHROMOSOME 14 SYNDROME	0.012796284	0.417994574096142
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012796284	0.417994574096142
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012796284	0.417994574096142
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012796283999999998	0.4179945740961419
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012796283999999998	0.4179945740961419
FUMARASE DEFICIENCY; FMRD	0.012796283999999998	0.4179945740961419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012796283999999998	0.4179945740961419
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.012796283999999998	0.4179945740961419
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796283999999998	0.4179945740961419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012796283999999998	0.4179945740961419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796283999999998	0.4179945740961419
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012796283999999998	0.4179945740961419
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.012796283999999998	0.4179945740961419
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012796283999999998	0.4179945740961419
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.012714873	0.4153352586048837
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.012714873	0.4153352586048837
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.012714873	0.4153352586048837
GAUCHER DISEASE TYPE 3	0.01270754	0.4150957238921618
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01270754	0.4150957238921618
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.012695689999999999	0.41470863997756285
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.41097117328923694
VERVERI-BRADY SYNDROME; VERBRAS	0.01238433	0.40453796928984026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.4001738839741935
DESMOSTEROLOSIS	0.01225073	0.4001738839741935
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.012173454	0.39764963953667926
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.012173454	0.39764963953667926
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.012173454	0.39764963953667926
CEREBELLAR ATAXIA, CAYMAN TYPE	0.012173454	0.39764963953667926
PEROXISOME BIOGENESIS DISORDER 6B	0.012173454	0.39764963953667926
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.012173454	0.39764963953667926
SPINOCEREBELLAR ATAXIA TYPE 29	0.012173454	0.39764963953667926
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.012173454	0.39764963953667926
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.012173454	0.39764963953667926
SPINOCEREBELLAR ATAXIA 5; SCA5	0.012173454	0.39764963953667926
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.012173454	0.39764963953667926
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.012173454	0.39764963953667926
MEDULLOBLASTOMA	0.012173454	0.39764963953667926
COWDEN SYNDROME 5; CWS5	0.012169319	0.3975145684829352
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.012169319	0.3975145684829352
COWDEN SYNDROME 6; CWS6	0.012169319	0.3975145684829352
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.012169319	0.3975145684829352
GLUTATHIONE SYNTHETASE DEFICIENCY	0.012169319	0.3975145684829352
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.012169319	0.3975145684829352
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.012169319	0.3975145684829352
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.012169319	0.3975145684829352
PERLMAN SYNDROME	0.012039854	0.3932855542210325
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.3932855542210325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.3932855542210325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.012039854	0.3932855542210325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.3932855542210325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.3932855542210325
WRINKLY SKIN SYNDROME	0.012039854	0.3932855542210325
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.3932855542210325
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.3932855542210325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.012039854	0.3932855542210325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.3932855542210325
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.3932855542210325
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.0116279	0.37982894941473083
UNVERRICHT-LUNDBORG DISEASE	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA TYPE 40	0.0116279	0.37982894941473083
PARKINSONIAN-PYRAMIDAL SYNDROME	0.0116279	0.37982894941473083
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA 40; SCA40	0.0116279	0.37982894941473083
EPISODIC ATAXIA, TYPE 8	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0116279	0.37982894941473083
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0116279	0.37982894941473083
DEMENTIA, FAMILIAL DANISH	0.0116279	0.37982894941473083
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.0116279	0.37982894941473083
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA TYPE 35	0.0116279	0.37982894941473083
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.0116279	0.37982894941473083
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.0116279	0.37982894941473083
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA TYPE 6	0.0116279	0.37982894941473083
BOUCHER-NEUHAUSER SYNDROME	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA 34; SCA34	0.0116279	0.37982894941473083
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0116279	0.37982894941473083
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0116279	0.37982894941473083
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.0116279	0.37982894941473083
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.0116279	0.37982894941473083
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.0116279	0.37982894941473083
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.3754648640990841
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.3754648640990841
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.3754648640990841
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.3754648640990841
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.3754648640990841
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.011494299999999999	0.3754648640990841
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.3754648640990841
MELAS	0.01123511	0.36699834259487407
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.011102663	0.3626719203807913
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.011036084	0.360497096756312
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.011024234	0.3601100128417131
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.011020098999999998	0.359974941787969
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.010561244000000001	0.34498630131258695
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.010561244000000001	0.34498630131258695
OLIVER SYNDROME	0.01052348	0.34375272857411326
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.34267640663436355
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.32716561119063853
MICROHYDRANENCEPHALY; MHAC	0.01001569	0.32716561119063853
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.32716561119063853
PAINE SYNDROME	0.01001569	0.32716561119063853
BIOTINIDASE DEFICIENCY	0.009804814	0.3202772814374775
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3202772814374775
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3202772814374775
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3202772814374775
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3202772814374775
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3202772814374775
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.3202772814374775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3202772814374775
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3202772814374775
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.32014221038373347
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.32014221038373347
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3024565913155291
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.3024565913155291
GLYCINE ENCEPHALOPATHY	0.00925926	0.3024565913155291
GAUCHER DISEASE TYPE 2	0.00925926	0.3024565913155291
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3024565913155291
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3024565913155291
CARNOSINEMIA	0.00925926	0.3024565913155291
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3024565913155291
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3024565913155291
CARNOSINASE DEFICIENCY	0.00925926	0.3024565913155291
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3024565913155291
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3024565913155291
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3024565913155291
HYDROXYLYSINURIA	0.00925926	0.3024565913155291
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008728113	0.2851065103039288
HSD10 DISEASE	0.008728113	0.2851065103039288
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.008344233999999999	0.27256698405478863
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.008344233999999999	0.27256698405478863
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.27256698405478863
1Q44 MICRODELETION SYNDROME	0.008344233999999999	0.27256698405478863
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.008186694	0.26742089123572443
COCKAYNE SYNDROME A; CSA	0.008182558999999999	0.26728582018198044
1P36 DELETION SYNDROME	0.008016483000000001	0.2618608962831681
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.008016483000000001	0.2618608962831681
SMITH-MAGENIS SYNDROME	0.008016483	0.26186089628316805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.008004633	0.26147381236856915
JOUBERT SYNDROME WITH RENAL DEFECT	0.007971683	0.26039749042881943
NIEMANN-PICK DISEASE TYPE C	0.007971683	0.26039749042881943
JOUBERT SYNDROME WITH OCULAR DEFECT	0.007971683	0.26039749042881943
OROFACIODIGITAL SYNDROME TYPE 6	0.007971683	0.26039749042881943
JOUBERT SYNDROME	0.007971683	0.26039749042881943
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.007971683	0.26039749042881943
HALLERMANN-STREIFF SYNDROME; HSS	0.00779868	0.2547462939328402
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00779868	0.2547462939328402
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.2547462939328402
AMISH LETHAL MICROCEPHALY	0.00779868	0.2547462939328402
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00779868	0.2547462939328402
MENTAL RETARDATION, X-LINKED 12; MRX12	0.007641139999999999	0.249600201113776
PELGER-HUET ANOMALY; PHA	0.007587804	0.24785796417967923
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.24785796417967923
W SYNDROME	0.007587804	0.24785796417967923
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.24785796417967923
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.24785796417967923
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.24785796417967923
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.24785796417967923
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.24785796417967923
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.24772289312593523
3Q29 MICRODELETION SYNDROME	0.007475064	0.2441752772149636
12Q14 MICRODELETION SYNDROME	0.007463214	0.24378819330036472
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.007459079	0.24365312224662072
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007430264000000001	0.24271187136061506
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.007430264	0.242711871360615
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.007430264	0.242711871360615
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.007430264	0.242711871360615
KUFOR-RAKEB SYNDROME	0.007426129	0.242576800306871
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.007426129	0.242576800306871
ALEXANDER DISEASE	0.007426129	0.242576800306871
KALLMANN SYNDROME	0.007426129	0.242576800306871
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.007426129	0.242576800306871
CHOREOACANTHOCYTOSIS	0.007426129	0.242576800306871
SPONTANEOUS PERIODIC HYPOTHERMIA	0.007426129	0.242576800306871
SIALIDOSIS TYPE 1	0.007426129	0.242576800306871
ATAXIA-TELANGIECTASIA	0.007426129	0.242576800306871
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007426129	0.242576800306871
TRISOMY X	0.007248203000000001	0.23676479249345972
48,XXYY SYNDROME	0.007248203	0.23676479249345972
48,XXXY SYNDROME	0.007248203	0.23676479249345972
49,XXXXY SYNDROME	0.007248203	0.23676479249345972
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.2300372740577308
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.2300372740577308
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.2300372740577308
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.2300372740577308
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.2300372740577308
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.2300372740577308
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.2300372740577308
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.2300372740577308
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.2300372740577308
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.2300372740577308
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.2300372740577308
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.2300372740577308
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.2300372740577308
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.2300372740577308
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.2300372740577308
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.2300372740577308
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.2300372740577308
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.2300372740577308
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.2300372740577308
WILLIAMS SYNDROME	0.00691766	0.2259675031784163
ATAXIA WITH VITAMIN E DEFICIENCY	0.0068847100000000005	0.22489118123866664
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0068847100000000005	0.22489118123866664
BEHR SYNDROME	0.0068847100000000005	0.22489118123866664
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.0068847100000000005	0.22489118123866664
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0068847100000000005	0.22489118123866664
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0068847100000000005	0.22489118123866664
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0068847100000000005	0.22489118123866664
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0068847100000000005	0.22489118123866664
CLASSIC GALACTOSEMIA	0.0068847100000000005	0.22489118123866664
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0068847100000000005	0.22489118123866664
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.0068847100000000005	0.22489118123866664
CORTICOBASAL SYNDROME	0.0068847100000000005	0.22489118123866664
OCULODENTODIGITAL DYSPLASIA	0.0067144990000000005	0.2193311862861102
OROFACIODIGITAL SYNDROME TYPE 1	0.006702649	0.21894410237151127
MASA SYNDROME	0.006173080000000001	0.2016455672179058
NON-DISTAL MONOSOMY 10Q	0.006173080000000001	0.2016455672179058
DOWN SYNDROME	0.006173080000000001	0.2016455672179058
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.006173080000000001	0.2016455672179058
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.006173080000000001	0.2016455672179058
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.005291683	0.17285446164189502
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.005291683	0.17285446164189502
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.005291683	0.17285446164189502
16P13.2 MICRODELETION SYNDROME	0.005291683	0.17285446164189502
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.005291683	0.17285446164189502
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.005279832999999999	0.1724673777272961
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.005279832999999999	0.1724673777272961
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005279832999999999	0.1724673777272961
AICARDI-GOUTIÈRES SYNDROME	0.005279832999999999	0.1724673777272961
GALACTOSEMIA	0.005279832999999999	0.1724673777272961
CLASSIC PHENYLKETONURIA	0.005279832999999999	0.1724673777272961
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.005279832999999999	0.1724673777272961
JABERI-ELAHI SYNDROME; JABELS	0.005279832999999999	0.1724673777272961
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.005279832999999999	0.1724673777272961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.005279832999999999	0.1724673777272961
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.005279832999999999	0.1724673777272961
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.005279832999999999	0.1724673777272961
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.005279832999999999	0.1724673777272961
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.004750264000000001	0.1551688425736906
RIDDLE SYNDROME	0.004750264000000001	0.1551688425736906
2P15P16.1 MICRODELETION SYNDROME	0.004750264000000001	0.1551688425736906
TETRASOMY 18P	0.004746129	0.1550337715199466
WOLCOTT-RALLISON SYNDROME	0.004746129	0.1550337715199466
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.004746129	0.1550337715199466
PELIZAEUS-MERZBACHER DISEASE	0.004746129	0.1550337715199466
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.004746129	0.1550337715199466
COFFIN-LOWRY SYNDROME	0.004746129	0.1550337715199466
PEDIATRIC-ONSET GRAVES DISEASE	0.004738414	0.1547817586590917
AICARDI-GOUTIERES SYNDROME 6	0.004738414	0.1547817586590917
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004738414	0.1547817586590917
TYROSINEMIA TYPE 2	0.004734279	0.1546466876053477
CHROMOSOME 18Q DELETION SYNDROME	0.004734279	0.1546466876053477
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.004734279	0.1546466876053477
COCKAYNE SYNDROME	0.004734279	0.1546466876053477
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.004568203000000001	0.1492217637065353
FILIPPI SYNDROME	0.004568203000000001	0.1492217637065353
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004568203000000001	0.1492217637065353
19P13.12 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.004568203000000001	0.1492217637065353
6Q25 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
RUBINSTEIN-TAYBI SYNDROME	0.004568203000000001	0.1492217637065353
2Q31.1 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
1Q21.1 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
COHEN SYNDROME	0.004568203000000001	0.1492217637065353
20Q11.2 MICRODUPLICATION SYNDROME	0.004568203000000001	0.1492217637065353
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.004568203000000001	0.1492217637065353
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004568203000000001	0.1492217637065353
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004568203000000001	0.1492217637065353
2Q37 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.004568203000000001	0.1492217637065353
RUVALCABA SYNDROME	0.004568203000000001	0.1492217637065353
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.004568203000000001	0.1492217637065353
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004568203000000001	0.1492217637065353
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004568203000000001	0.1492217637065353
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004568203000000001	0.1492217637065353
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.004568203000000001	0.1492217637065353
DISTAL MONOSOMY 10Q	0.004568203	0.14922176370653528
PETERS-PLUS SYNDROME; PTRPLS	0.004568203	0.14922176370653528
DPAGT1-CDG	0.004568203	0.14922176370653528
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.14814544176678562
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.14814544176678562
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.004535253	0.14814544176678562
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.004535253	0.14814544176678562
FREE SIALIC ACID STORAGE DISEASE	0.004535253	0.14814544176678562
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.004535253	0.14814544176678562
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.004535253	0.14814544176678562
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.14814544176678562
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.14814544176678562
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.004535253	0.14814544176678562
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.14814544176678562
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.004535253	0.14814544176678562
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.14814544176678562
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.004535253	0.14814544176678562
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.14814544176678562
INCONTINENTIA PIGMENTI	0.004535253	0.14814544176678562
L1 SYNDROME	0.004535253	0.14814544176678562
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0045352529999999995	0.14814544176678557
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0045234030000000005	0.14775835785218672
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.004523403	0.1477583578521867
CITRULLINEMIA TYPE II	0.004523403	0.1477583578521867
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.004523403	0.1477583578521867
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.004523403	0.1477583578521867
SIALIDOSIS TYPE 2	0.004523403	0.1477583578521867
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.004523403	0.1477583578521867
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004523403	0.1477583578521867
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004523403	0.1477583578521867
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.004523403	0.1477583578521867
ADULT-ONSET DYSTONIA-PARKINSONISM	0.004523403	0.1477583578521867
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004523403	0.1477583578521867
MENTAL RETARDATION, X-LINKED 104; MRX104	0.004523403	0.1477583578521867
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.004523403	0.1477583578521867
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.004523403	0.1477583578521867
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004523403	0.1477583578521867
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.004523403	0.1477583578521867
CHÉDIAK-HIGASHI SYNDROME	0.004523403	0.1477583578521867
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.004523403	0.1477583578521867
METHYLMALONIC ACIDURIA, CBLA TYPE	0.004523403	0.1477583578521867
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00420471	0.1373481524517422
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00420471	0.1373481524517422
MUCOLIPIDOSIS TYPE IV	0.00420471	0.1373481524517422
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00420471	0.1373481524517422
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00420471	0.1373481524517422
SCHWARTZ-JAMPEL SYNDROME	0.00420471	0.1373481524517422
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.00419286	0.13696106853714327
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00419286	0.13696106853714327
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00419286	0.13696106853714327
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00419286	0.13696106853714327
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004026784	0.13153614463833088
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.004026784	0.13153614463833088
TRISOMY 9P	0.004026784	0.13153614463833088
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.004026784	0.13153614463833088
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.004026784	0.13153614463833088
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.004026784	0.13153614463833088
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.004026784	0.13153614463833088
%300712 CRANIOFACIOSKELETAL SYNDROME	0.004026784	0.13153614463833088
LIG4 SYNDROME	0.004026784	0.13153614463833088
FANCONI ANEMIA	0.004026784	0.13153614463833088
17Q21.31 MICRODUPLICATION SYNDROME	0.004026784	0.13153614463833088
2Q32Q33 MICRODELETION SYNDROME	0.004026784	0.13153614463833088
ROBERTS SYNDROME	0.004026784	0.13153614463833088
6Q16 MICRODELETION SYNDROME	0.004026784	0.13153614463833088
ROIFMAN SYNDROME; RFMN	0.004026784	0.13153614463833088
TRISOMY 17P	0.004026784	0.13153614463833088
PENTASOMY X	0.004026784	0.13153614463833088
PETERS PLUS SYNDROME	0.004026784	0.13153614463833088
EAR-PATELLA-SHORT STATURE SYNDROME	0.004026784	0.13153614463833088
MIETENS SYNDROME	0.004026784	0.13153614463833088
CHARGE SYNDROME	0.004026784	0.13153614463833088
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.0040226490000000005	0.13140107358458689
RETT SYNDROME	0.0040226490000000005	0.13140107358458689
DISTAL MONOSOMY 3P	0.0040226490000000005	0.13140107358458689
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.0040226490000000005	0.13140107358458689
2Q23.1 MICRODELETION SYNDROME	0.0040226490000000005	0.13140107358458689
BOWEN-CONRADI SYNDROME	0.0040226490000000005	0.13140107358458689
WIEDEMANN-STEINER SYNDROME	0.0040226490000000005	0.13140107358458689
SECKEL SYNDROME 1; SCKL1	0.0040226490000000005	0.13140107358458689
HENNEKAM-BEEMER SYNDROME	0.0040226490000000005	0.13140107358458689
DISTAL MONOSOMY 7Q36	0.0040226490000000005	0.13140107358458689
BRANCHIOOCULOFACIAL SYNDROME	0.0040226490000000005	0.13140107358458689
DUBOWITZ SYNDROME	0.0040226490000000005	0.13140107358458689
RENPENNING SYNDROME 1; RENS1	0.0040226490000000005	0.13140107358458689
RENPENNING SYNDROME	0.0040226490000000005	0.13140107358458689
MICROPHTHALMIA, LENZ TYPE	0.0040226490000000005	0.13140107358458689
C SYNDROME	0.0040226490000000005	0.13140107358458689
TRISOMY 8P	0.0040226490000000005	0.13140107358458689
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0040226490000000005	0.13140107358458689
CORNELIA DE LANGE SYNDROME	0.004022649	0.13140107358458683
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.004022649	0.13140107358458683
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13045982269858117
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13045982269858117
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13045982269858117
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.13045982269858117
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.13045982269858117
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13045982269858117
JOUBERT SYNDROME 24	0.003993834	0.13045982269858117
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13045982269858117
FRIED SYNDROME	0.003993834	0.13045982269858117
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13045982269858117
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13045982269858117
COHEN-GIBSON SYNDROME; COGIS	0.003993834	0.13045982269858117
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13032475164483717
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.003989699	0.13032475164483717
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.003989699	0.13032475164483717
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.003989699	0.13032475164483717
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13032475164483717
TENORIO SYNDROME; TNORS	0.003989699	0.13032475164483717
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.003989699	0.13032475164483717
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.003989699	0.13032475164483717
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13032475164483717
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.003989699	0.13032475164483717
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13032475164483717
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13032475164483717
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003989699	0.13032475164483717
LYNCH SYNDROME	0.003989699	0.13032475164483717
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.003989699	0.13032475164483717
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.003989699	0.13032475164483717
FAMILIAL DYSAUTONOMIA	0.003989699	0.13032475164483717
SUBEPENDYMOMA	0.003989699	0.13032475164483717
EPENDYMOMA	0.003989699	0.13032475164483717
CENTRONUCLEAR MYOPATHY	0.003989699	0.13032475164483717
MUSCLE-EYE-BRAIN DISEASE	0.003989699	0.13032475164483717
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13032475164483717
BEHÇET DISEASE	0.003989699	0.13032475164483717
ALZHEIMER DISEASE 3; AD	0.003989699	0.13032475164483717
PARTINGTON SYNDROME	0.003989699	0.13032475164483717
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13032475164483717
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13032475164483717
CADASIL	0.003989699	0.13032475164483717
HEREDITARY HYPEREKPLEXIA	0.003989699	0.13032475164483717
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13032475164483717
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13032475164483717
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13032475164483717
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13032475164483717
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.003981984	0.1300727387839823
GABRIELE-DE VRIES SYNDROME; GADEVS	0.003981984	0.1300727387839823
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003981984	0.1300727387839823
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.003981984	0.1300727387839823
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.003981984	0.1300727387839823
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.003981984	0.1300727387839823
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.003981984	0.1300727387839823
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.003981984	0.1300727387839823
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.003981984	0.1300727387839823
PEROXISOME BIOGENESIS DISORDER 5B	0.003981984	0.1300727387839823
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.003981984	0.1300727387839823
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.003981984	0.1300727387839823
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.003981984	0.1300727387839823
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.003981984	0.1300727387839823
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.003981984	0.1300727387839823
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.003977849	0.1299376677302383
CYSTATHIONINURIA	0.003977849	0.1299376677302383
DDOST-CDG	0.003977849	0.1299376677302383
NIPAH VIRUS DISEASE	0.003977849	0.1299376677302383
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.003977849	0.1299376677302383
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.003977849	0.1299376677302383
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.003977849	0.1299376677302383
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.003977849	0.1299376677302383
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.003977849	0.1299376677302383
SNEDDON SYNDROME	0.003977849	0.1299376677302383
INHERITED CREUTZFELDT-JAKOB DISEASE	0.003977849	0.1299376677302383
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.003977849	0.1299376677302383
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.003977849	0.1299376677302383
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.003977849	0.1299376677302383
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.003977849	0.1299376677302383
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003977849	0.1299376677302383
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.003977849	0.1299376677302383
TSH-SECRETING PITUITARY ADENOMA	0.003977849	0.1299376677302383
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003977849	0.1299376677302383
CEREBROTENDINOUS XANTHOMATOSIS	0.003977849	0.1299376677302383
INSULINOMA	0.003977849	0.1299376677302383
4Q21 MICRODELETION SYNDROME	0.003977849	0.1299376677302383
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.003977849	0.1299376677302383
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.003977849	0.1299376677302383
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.003977849	0.1299376677302383
MERCURY POISONING	0.003977849	0.1299376677302383
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.003977849	0.1299376677302383
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.003977849	0.1299376677302383
SCRUB TYPHUS	0.003977849	0.1299376677302383
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.003977849	0.1299376677302383
GM1 GANGLIOSIDOSIS	0.003977849	0.1299376677302383
SNEDDON SYNDROME	0.003977849	0.1299376677302383
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.003977849	0.1299376677302383
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.003977849	0.1299376677302383
ENCEPHALITIS LETHARGICA	0.003977849	0.1299376677302383
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.003977849	0.1299376677302383
CRIGLER-NAJJAR SYNDROME TYPE 1	0.003977849	0.1299376677302383
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.003977849	0.1299376677302383
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0038117730000000005	0.12451274383142588
8Q24.3 MICRODELETION SYNDROME	0.0038117730000000005	0.12451274383142588
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0038117730000000005	0.12451274383142588
RECOMBINANT 8 SYNDROME	0.003811773	0.12451274383142585
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.003811773	0.12451274383142585
RECOMBINANT CHROMOSOME 8 SYNDROME	0.003811773	0.12451274383142585
15Q11Q13 MICRODUPLICATION SYNDROME	0.003811773	0.12451274383142585
WIEDEMANN-STEINER SYNDROME; WDSTS	0.003811773	0.12451274383142585
11Q22.2Q22.3 MICRODELETION SYNDROME	0.003811773	0.12451274383142585
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.003811773	0.12451274383142585
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003811773	0.12451274383142585
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003811773	0.12451274383142585
TETRASOMY 5P	0.003811773	0.12451274383142585
CHROMOSOME 16P13.2 DELETION SYNDROME	0.003811773	0.12451274383142585
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.003811773	0.12451274383142585
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003811773	0.12451274383142585
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.003811773	0.12451274383142585
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.003811773	0.12451274383142585
CATEL-MANZKE SYNDROME; CATMANS	0.003811773	0.12451274383142585
CORNELIA DE LANGE SYNDROME 3	0.003811773	0.12451274383142585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.003811773	0.12451274383142585
MONOSOMY 22Q13.3	0.003811773	0.12451274383142585
TETRASOMY 9P	0.003811773	0.12451274383142585
MONOSOMY 22	0.00348123	0.11371545451638244
MICROTRIPLICATION 11Q24.1	0.00348123	0.11371545451638244
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00348123	0.11371545451638244
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00348123	0.11371545451638244
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00348123	0.11371545451638244
MICROCEPHALY-CARDIOMYOPATHY	0.00348123	0.11371545451638244
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00348123	0.11371545451638244
ROIFMAN SYNDROME	0.00348123	0.11371545451638244
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00348123	0.11371545451638244
FEINGOLD SYNDROME	0.00348123	0.11371545451638244
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00348123	0.11371545451638244
RING CHROMOSOME 7 SYNDROME	0.00348123	0.11371545451638244
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00348123	0.11371545451638244
SECKEL SYNDROME 5; SCKL5	0.00348123	0.11371545451638244
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00348123	0.11371545451638244
SECKEL SYNDROME 2; SCKL2	0.00348123	0.11371545451638244
JOHANSON-BLIZZARD SYNDROME; JBS	0.00348123	0.11371545451638244
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00348123	0.11371545451638244
ANONYCHIA-MICROCEPHALY SYNDROME	0.00348123	0.11371545451638244
RING CHROMOSOME 1 SYNDROME	0.00348123	0.11371545451638244
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00348123	0.11371545451638244
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00348123	0.11371545451638244
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00348123	0.11371545451638244
MONOSOMY 13Q14	0.00348123	0.11371545451638244
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00348123	0.11371545451638244
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00348123	0.11371545451638244
19Q13.11 MICRODELETION SYNDROME	0.00348123	0.11371545451638244
DUBOWITZ SYNDROME	0.00348123	0.11371545451638244
DISTAL MONOSOMY 10P	0.00348123	0.11371545451638244
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00348123	0.11371545451638244
MEIER-GORLIN SYNDROME 1; MGORS1	0.00348123	0.11371545451638244
BOWEN-CONRADI SYNDROME	0.00348123	0.11371545451638244
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00348123	0.11371545451638244
CRANIOFRONTONASAL DYSPLASIA	0.00348123	0.11371545451638244
CEREBROCOSTOMANDIBULAR SYNDROME	0.00348123	0.11371545451638244
SECKEL SYNDROME	0.00348123	0.11371545451638244
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00348123	0.11371545451638244
3MC SYNDROME 1	0.00348123	0.11371545451638244
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00348123	0.11371545451638244
BLOOM SYNDROME	0.00348123	0.11371545451638244
HALLERMANN-STREIFF SYNDROME	0.00348123	0.11371545451638244
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00348123	0.11371545451638244
JACOBSEN SYNDROME	0.00348123	0.11371545451638244
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00348123	0.11371545451638244
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00348123	0.11371545451638244
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00348123	0.11371545451638244
ERMINE PHENOTYPE	0.00348123	0.11371545451638244
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.11263913257663276
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.11263913257663276
BARTH SYNDROME; BTHS	0.00344828	0.11263913257663276
BENIGN HEREDITARY CHOREA	0.00344828	0.11263913257663276
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11263913257663276
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.11263913257663276
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.11263913257663276
THORACOMELIC DYSPLASIA	0.00344828	0.11263913257663276
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11263913257663276
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11263913257663276
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11263913257663276
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11263913257663276
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00344828	0.11263913257663276
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11263913257663276
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11263913257663276
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00344828	0.11263913257663276
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.11263913257663276
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11263913257663276
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.11263913257663276
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.11263913257663276
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11263913257663276
POLYMYOSITIS	0.00344828	0.11263913257663276
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00344828	0.11263913257663276
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11263913257663276
NONAKA MYOPATHY	0.00344828	0.11263913257663276
BRITTLE CORNEA SYNDROME 2; BCS2	0.00344828	0.11263913257663276
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.11263913257663276
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11263913257663276
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11263913257663276
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11263913257663276
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11263913257663276
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11263913257663276
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11263913257663276
MOEBIUS SYNDROME; MBS	0.00344828	0.11263913257663276
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11263913257663276
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11263913257663276
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11263913257663276
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.11263913257663276
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11263913257663276
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11263913257663276
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11263913257663276
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11263913257663276
OSTEOGENESIS IMPERFECTA	0.00344828	0.11263913257663276
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11263913257663276
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11263913257663276
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11263913257663276
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11263913257663276
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11263913257663276
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11263913257663276
KUSKOKWIM SYNDROME	0.00344828	0.11263913257663276
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11263913257663276
MELNICK-NEEDLES SYNDROME	0.00344828	0.11263913257663276
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11263913257663276
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11263913257663276
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00344828	0.11263913257663276
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11263913257663276
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11263913257663276
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.11263913257663276
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11263913257663276
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11263913257663276
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11263913257663276
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11263913257663276
TRISOMY XQ28	0.00344828	0.11263913257663276
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11263913257663276
MAST SYNDROME	0.00344828	0.11263913257663276
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11263913257663276
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11263913257663276
TRISOMY 20P	0.00344828	0.11263913257663276
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11263913257663276
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11263913257663276
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11263913257663276
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.11263913257663276
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11263913257663276
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11263913257663276
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00344828	0.11263913257663276
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11263913257663276
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.11263913257663276
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11263913257663276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11263913257663276
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11263913257663276
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11263913257663276
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.11263913257663276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11263913257663276
CYSTINOSIS	0.00344828	0.11263913257663276
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.11263913257663276
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00344828	0.11263913257663276
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11263913257663276
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11263913257663276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.11263913257663276
ADULT POLYGLUCOSAN BODY DISEASE	0.00344828	0.11263913257663276
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11263913257663276
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11263913257663276
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11263913257663276
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11263913257663276
NEMALINE MYOPATHY 6	0.00344828	0.11263913257663276
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.11263913257663276
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11263913257663276
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11263913257663276
ROUSSY-LÉVY SYNDROME	0.00344828	0.11263913257663276
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11263913257663276
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.11263913257663276
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11263913257663276
MYOTONIA FLUCTUANS	0.00344828	0.11263913257663276
BRITTLE CORNEA SYNDROME	0.00344828	0.11263913257663276
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11263913257663276
RHEUMATIC FEVER	0.00344828	0.11263913257663276
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11263913257663276
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11263913257663276
NEUROFERRITINOPATHY	0.00344828	0.11263913257663276
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11263913257663276
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11263913257663276
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.11263913257663276
KENNEDY DISEASE	0.00344828	0.11263913257663276
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00344828	0.11263913257663276
SPONASTRIME DYSPLASIA	0.00344828	0.11263913257663276
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11263913257663276
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11263913257663276
LERI PLEONOSTEOSIS	0.00344828	0.11263913257663276
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11263913257663276
MYOTONIA PERMANENS	0.00344828	0.11263913257663276
PSEUDOACHONDROPLASIA	0.00344828	0.11263913257663276
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00343643	0.11225204866203385
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00343643	0.11225204866203385
WILSON DISEASE	0.00343643	0.11225204866203385
DYSTONIA 11, MYOCLONIC	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 42	0.00343643	0.11225204866203385
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00343643	0.11225204866203385
MONOMELIC AMYOTROPHY	0.00343643	0.11225204866203385
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00343643	0.11225204866203385
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.00343643	0.11225204866203385
TYPHOID	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA TYPE 21	0.00343643	0.11225204866203385
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00343643	0.11225204866203385
PARKINSON DISEASE 21; PARK21	0.00343643	0.11225204866203385
EPISODIC ATAXIA, TYPE 1; EA1	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA TYPE 31	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00343643	0.11225204866203385
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00343643	0.11225204866203385
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00343643	0.11225204866203385
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00343643	0.11225204866203385
SPASTIC PARAPARESIS AND DEAFNESS	0.00343643	0.11225204866203385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00343643	0.11225204866203385
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00343643	0.11225204866203385
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00343643	0.11225204866203385
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00343643	0.11225204866203385
DYSTONIA 3, TORSION, X-LINKED	0.00343643	0.11225204866203385
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.00343643	0.11225204866203385
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00343643	0.11225204866203385
MOHR-TRANEBJAERG SYNDROME	0.00343643	0.11225204866203385
O'SULLIVAN-MCLEOD SYNDROME	0.00343643	0.11225204866203385
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.00343643	0.11225204866203385
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00343643	0.11225204866203385
OPTIC ATROPHY 2	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00343643	0.11225204866203385
GABRIELE-DE VRIES SYNDROME	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00343643	0.11225204866203385
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00343643	0.11225204866203385
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.00343643	0.11225204866203385
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA TYPE 14	0.00343643	0.11225204866203385
CEREBELLAR HYPOPLASIA	0.00343643	0.11225204866203385
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00343643	0.11225204866203385
PERRY SYNDROME	0.00343643	0.11225204866203385
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.00343643	0.11225204866203385
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00343643	0.11225204866203385
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00343643	0.11225204866203385
SÉZARY SYNDROME	0.00343643	0.11225204866203385
GLUTATHIONURIA	0.00343643	0.11225204866203385
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.00343643	0.11225204866203385
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00343643	0.11225204866203385
PERRY SYNDROME	0.00343643	0.11225204866203385
DYSTONIA 13, TORSION	0.00343643	0.11225204866203385
ACERULOPLASMINEMIA	0.00343643	0.11225204866203385
THYROTOXIC PERIODIC PARALYSIS	0.00343643	0.11225204866203385
NEUROLEPTIC MALIGNANT SYNDROME	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA TYPE 38	0.00343643	0.11225204866203385
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 18	0.00343643	0.11225204866203385
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00343643	0.11225204866203385
NON-FUNCTIONING PARAGANGLIOMA	0.00343643	0.11225204866203385
YOUNG-ONSET PARKINSON DISEASE	0.00343643	0.11225204866203385
TETANUS	0.00343643	0.11225204866203385
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00343643	0.11225204866203385
MYOPATHY, SPHEROID BODY	0.00343643	0.11225204866203385
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00343643	0.11225204866203385
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00343643	0.11225204866203385
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00343643	0.11225204866203385
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.00343643	0.11225204866203385
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.00343643	0.11225204866203385
PRIMARY DYSTONIA, DYT2 TYPE	0.00343643	0.11225204866203385
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00343643	0.11225204866203385
AMISH NEMALINE MYOPATHY	0.00343643	0.11225204866203385
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00343643	0.11225204866203385
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.00343643	0.11225204866203385
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00343643	0.11225204866203385
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00343643	0.11225204866203385
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00343643	0.11225204866203385
PRIMARY ORTHOSTATIC TREMOR	0.00343643	0.11225204866203385
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00343643	0.11225204866203385
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00343643	0.11225204866203385
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0032703540000000005	0.10682712476322147
CHAR SYNDROME	0.0032703540000000005	0.10682712476322147
POPOV-CHANG SYNDROME; POPCHAS	0.0032703540000000005	0.10682712476322147
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.0032703540000000005	0.10682712476322147
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0032703540000000005	0.10682712476322147
LARSEN-LIKE SYNDROME	0.0032703540000000005	0.10682712476322147
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0032703540000000005	0.10682712476322147
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.0032703540000000005	0.10682712476322147
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0032703540000000005	0.10682712476322147
TRISOMY 12P	0.0032703540000000005	0.10682712476322147
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0032703540000000005	0.10682712476322147
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.0032703540000000005	0.10682712476322147
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0032703540000000005	0.10682712476322147
DISTAL MONOSOMY 6P	0.0032703540000000005	0.10682712476322147
ARTERIAL TORTUOSITY SYNDROME	0.0032703540000000005	0.10682712476322147
17P13.3 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.10682712476322147
DISTAL TRISOMY 18Q	0.0032703540000000005	0.10682712476322147
2Q23.1 MICRODUPLICATION SYNDROME	0.0032703540000000005	0.10682712476322147
CRANIOFRONTONASAL SYNDROME; CFNS	0.0032703540000000005	0.10682712476322147
14Q22Q23 MICRODELETION SYNDROME	0.0032703540000000005	0.10682712476322147
TETRASOMY X	0.0032703540000000005	0.10682712476322147
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.0032703540000000005	0.10682712476322147
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0032703540000000005	0.10682712476322147
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0032703540000000005	0.10682712476322147
CHAR SYNDROME	0.0032703540000000005	0.10682712476322147
FLOATING-HARBOR SYNDROME	0.0032703540000000005	0.10682712476322147
TEMTAMY SYNDROME	0.0032703540000000005	0.10682712476322147
AARSKOG-SCOTT SYNDROME	0.0032703540000000005	0.10682712476322147
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0032703540000000005	0.10682712476322147
SILVER-RUSSELL SYNDROME; SRS	0.0032703540000000005	0.10682712476322147
FRYNS SYNDROME	0.0032662190000000003	0.10669205370947746
ACROCALLOSAL SYNDROME; ACLS	0.0032662190000000003	0.10669205370947746
ZUNICH NEUROECTODERMAL SYNDROME	0.0032662190000000003	0.10669205370947746
PALLISTER-KILLIAN SYNDROME	0.0032662190000000003	0.10669205370947746
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.0032662190000000003	0.10669205370947746
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0032662190000000003	0.10669205370947746
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.0032662190000000003	0.10669205370947746
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0032662190000000003	0.10669205370947746
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.0032662190000000003	0.10669205370947746
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.0032662190000000003	0.10669205370947746
OHDO SYNDROME	0.0032662190000000003	0.10669205370947746
PROTEUS SYNDROME	0.0032662190000000003	0.10669205370947746
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0032662190000000003	0.10669205370947746
SAETHRE-CHOTZEN SYNDROME	0.0032662190000000003	0.10669205370947746
8P INVERTED DUPLICATION/DELETION SYNDROME	0.0032662190000000003	0.10669205370947746
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.0032662190000000003	0.10669205370947746
15Q OVERGROWTH SYNDROME	0.0032662190000000003	0.10669205370947746
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.0032662190000000003	0.10669205370947746
WARBURG MICRO SYNDROME 3; WARBM3	0.0032662190000000003	0.10669205370947746
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0032662190000000003	0.10669205370947746
MILLER-DIEKER SYNDROME	0.0032662190000000003	0.10669205370947746
HAND-FOOT-GENITAL SYNDROME; HFG	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY, TYPE A3	0.0027248000000000003	0.08900643464127303
KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY	0.0027248000000000003	0.08900643464127303
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0027248000000000003	0.08900643464127303
BANKI SYNDROME	0.0027248000000000003	0.08900643464127303
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0027248000000000003	0.08900643464127303
ALAGILLE SYNDROME	0.0027248000000000003	0.08900643464127303
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.0027248000000000003	0.08900643464127303
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.0027248000000000003	0.08900643464127303
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0027248000000000003	0.08900643464127303
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.08900643464127303
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.0027248000000000003	0.08900643464127303
HAND-FOOT-GENITAL SYNDROME	0.0027248000000000003	0.08900643464127303
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.0027248000000000003	0.08900643464127303
FLOATING-HARBOR SYNDROME	0.0027248000000000003	0.08900643464127303
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.0027248000000000003	0.08900643464127303
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.0027248000000000003	0.08900643464127303
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0027248000000000003	0.08900643464127303
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.0027248000000000003	0.08900643464127303
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0027248000000000003	0.08900643464127303
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.0027248000000000003	0.08900643464127303
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0027248000000000003	0.08900643464127303
WHITE FORELOCK WITH MALFORMATIONS	0.0027248000000000003	0.08900643464127303
HALLUX VARUS-PREAXIAL POLYSYNDACTYLY SYNDROME	0.0027248000000000003	0.08900643464127303
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0027248000000000003	0.08900643464127303
TOWNES-BROCKS SYNDROME	0.0027248000000000003	0.08900643464127303
DENTAL ANKYLOSIS	0.0027248000000000003	0.08900643464127303
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.0027248000000000003	0.08900643464127303
SYNPOLYDACTYLY 1	0.0027248000000000003	0.08900643464127303
URBAN-ROGERS-MEYER SYNDROME	0.0027248000000000003	0.08900643464127303
VELO-FACIAL-SKELETAL SYNDROME	0.0027248000000000003	0.08900643464127303
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0027248000000000003	0.08900643464127303
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.0027248000000000003	0.08900643464127303
SKELETAL DYSPLASIA WITH DELAYED EPIPHYSEAL AND CARPAL BONE OSSIFICATION	0.0027248000000000003	0.08900643464127303
KEIPERT SYNDROME	0.0027248000000000003	0.08900643464127303
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0027248000000000003	0.08900643464127303
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.0027248000000000003	0.08900643464127303
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.0027248000000000003	0.08900643464127303
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0027248000000000003	0.08900643464127303
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.0027248000000000003	0.08900643464127303
DESBUQUOIS SYNDROME	0.0027248000000000003	0.08900643464127303
METATROPIC DYSPLASIA	0.0027248000000000003	0.08900643464127303
PELVIS-SHOULDER DYSPLASIA	0.0027248000000000003	0.08900643464127303
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.0027248000000000003	0.08900643464127303
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.0027248000000000003	0.08900643464127303
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0027248000000000003	0.08900643464127303
3M SYNDROME	0.0027248000000000003	0.08900643464127303
PFEIFFER SYNDROME	0.0027248000000000003	0.08900643464127303
TALONAVICULAR COALITION	0.0027248000000000003	0.08900643464127303
FIBROCHONDROGENESIS 1; FBCG1	0.0027248000000000003	0.08900643464127303
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.0027248000000000003	0.08900643464127303
TETRALOGY OF FALLOT	0.0027248000000000003	0.08900643464127303
CLEIDORHIZOMELIC SYNDROME	0.0027248000000000003	0.08900643464127303
CLEIDOCRANIAL DYSPLASIA	0.0027248000000000003	0.08900643464127303
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.0027248000000000003	0.08900643464127303
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.0027248000000000003	0.08900643464127303
PROXIMAL SYMPHALANGISM	0.0027248000000000003	0.08900643464127303
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027248000000000003	0.08900643464127303
PENOSCROTAL TRANSPOSITION	0.0027248000000000003	0.08900643464127303
TETRALOGY OF FALLOT	0.0027248000000000003	0.08900643464127303
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY TYPE C	0.0027248000000000003	0.08900643464127303
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.0027248000000000003	0.08900643464127303
WT LIMB-BLOOD SYNDROME	0.0027248000000000003	0.08900643464127303
WILLIAMS-BEUREN SYNDROME; WBS	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY TYPE A1	0.0027248000000000003	0.08900643464127303
WEYERS ACROFACIAL DYSOSTOSIS	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY TYPE A2	0.0027248000000000003	0.08900643464127303
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.0027248000000000003	0.08900643464127303
OSLAM SYNDROME	0.0027248000000000003	0.08900643464127303
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0027248000000000003	0.08900643464127303
LIMB-MAMMARY SYNDROME	0.0027248000000000003	0.08900643464127303
SUMMITT SYNDROME	0.0027248000000000003	0.08900643464127303
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.0027248000000000003	0.08900643464127303
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0027248000000000003	0.08900643464127303
CATEL-MANZKE SYNDROME	0.0027248000000000003	0.08900643464127303
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.0027248000000000003	0.08900643464127303
FRANK-TER HAAR SYNDROME	0.0027248000000000003	0.08900643464127303
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0027248000000000003	0.08900643464127303
HYPERTELORISM, TEEBI TYPE	0.0027248000000000003	0.08900643464127303
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.0027248000000000003	0.08900643464127303
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0027248000000000003	0.08900643464127303
FETAL MINOXIDIL SYNDROME	0.0027248000000000003	0.08900643464127303
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027248000000000003	0.08900643464127303
MESOMELIA-SYNOSTOSES SYNDROME	0.0027248000000000003	0.08900643464127303
PERIPHERAL DYSOSTOSIS	0.0027248000000000003	0.08900643464127303
ROBIN SEQUENCE-OLIGODACTYLY SYNDROME	0.0027248000000000003	0.08900643464127303
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.0027248000000000003	0.08900643464127303
MOEBIUS SYNDROME	0.0027248000000000003	0.08900643464127303
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.0027248000000000003	0.08900643464127303
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.0027248000000000003	0.08900643464127303
FRAXE INTELLECTUAL DISABILITY	0.0027248000000000003	0.08900643464127303
GORDON SYNDROME	0.0027248000000000003	0.08900643464127303
FRONTONASAL DYSPLASIA	0.0027248000000000003	0.08900643464127303
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.0027248000000000003	0.08900643464127303
BRACHYDACTYLY, TYPE A1, D	0.0027248000000000003	0.08900643464127303
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.0027248000000000003	0.08900643464127303
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0027248000000000003	0.08900643464127303
SILVER-RUSSELL SYNDROME	0.0027248000000000003	0.08900643464127303
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.0027248000000000003	0.08900643464127303
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0027248000000000003	0.08900643464127303
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0027248000000000003	0.08900643464127303
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0027248000000000003	0.08900643464127303
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.0027248000000000003	0.08900643464127303
MOSAIC TRISOMY 8	0.0027248000000000003	0.08900643464127303
CRANIOFACIAL DYSSYNOSTOSIS	0.0027248000000000003	0.08900643464127303
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.0027248000000000003	0.08900643464127303
CRANIOECTODERMAL DYSPLASIA	0.0027248000000000003	0.08900643464127303
NAIL-PATELLA SYNDROME	0.0027248000000000003	0.08900643464127303
NOONAN SYNDROME	0.0027248000000000003	0.08900643464127303
MOLAR I REINCLUSION	0.0027248000000000003	0.08900643464127303
TEMPLE SYNDROME	0.0027248000000000003	0.08900643464127303
KERATOSIS PALMARIS ET PLANTARIS-CLINODACTYLY SYNDROME	0.0027248000000000003	0.08900643464127303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001843403	0.060215329065262266
DISTAL MONOSOMY 15Q	0.001843403	0.060215329065262266
COFFIN-SIRIS SYNDROME	0.001843403	0.060215329065262266
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001843403	0.060215329065262266
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.001843403	0.060215329065262266
MONOSOMY 18Q	0.001843403	0.060215329065262266
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.001843403	0.060215329065262266
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME	0.001843403	0.060215329065262266
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.060215329065262266
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001843403	0.060215329065262266
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001843403	0.060215329065262266
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001843403	0.060215329065262266
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.060215329065262266
CHROMOSOME 1P35 DELETION SYNDROME	0.001843403	0.060215329065262266
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.001843403	0.060215329065262266
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.060215329065262266
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001843403	0.060215329065262266
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001843403	0.060215329065262266
17Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.060215329065262266
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.060215329065262266
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.060215329065262266
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.060215329065262266
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001843403	0.060215329065262266
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.060215329065262266
COFFIN-SIRIS SYNDROME 5	0.001843403	0.060215329065262266
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001843403	0.060215329065262266
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001843403	0.060215329065262266
HEART AND BRAIN MALFORMATION SYNDROME	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001843403	0.060215329065262266
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001843403	0.060215329065262266
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001843403	0.060215329065262266
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.060215329065262266
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.060215329065262266
LISSENCEPHALY 8; LIS8	0.001843403	0.060215329065262266
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001843403	0.060215329065262266
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001843403	0.060215329065262266
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001843403	0.060215329065262266
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001843403	0.060215329065262266
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001843403	0.060215329065262266
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001843403	0.060215329065262266
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.060215329065262266
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001843403	0.060215329065262266
22Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.060215329065262266
AL KAISSI SYNDROME; ALKAS	0.001843403	0.060215329065262266
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.001843403	0.060215329065262266
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001843403	0.060215329065262266
22Q11.2 DELETION SYNDROME	0.001843403	0.060215329065262266
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.060215329065262266
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001843403	0.060215329065262266
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.060215329065262266
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.060215329065262266
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.001843403	0.060215329065262266
ALG11-CDG	0.001843403	0.060215329065262266
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.060215329065262266
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001843403	0.060215329065262266
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001843403	0.060215329065262266
CHROMOSOME 19P13.13 DELETION SYNDROME	0.001843403	0.060215329065262266
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.060215329065262266
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001843403	0.060215329065262266
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.001843403	0.060215329065262266
MEHMO SYNDROME; MEHMO	0.001843403	0.060215329065262266
WITTEVEEN-KOLK SYNDROME	0.001843403	0.060215329065262266
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001843403	0.060215329065262266
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001843403	0.060215329065262266
LATHOSTEROLOSIS	0.001843403	0.060215329065262266
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001843403	0.060215329065262266
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001843403	0.060215329065262266
PITT-HOPKINS SYNDROME	0.001843403	0.060215329065262266
MEVALONIC ACIDURIA	0.001843403	0.060215329065262266
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.060215329065262266
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001843403	0.060215329065262266
LISSENCEPHALY 4	0.001843403	0.060215329065262266
MULTIPLE SULFATASE DEFICIENCY	0.001843403	0.060215329065262266
15Q14 MICRODELETION SYNDROME	0.001843403	0.060215329065262266
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.060215329065262266
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001843403	0.060215329065262266
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001843403	0.060215329065262266
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.060215329065262266
COFFIN-SIRIS SYNDROME 4; CSS4	0.001843403	0.060215329065262266
COFFIN-SIRIS SYNDROME 3; CSS3	0.001843403	0.060215329065262266
KLEEFSTRA SYNDROME	0.001843403	0.060215329065262266
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001843403	0.060215329065262266
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001843403	0.060215329065262266
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001843403	0.060215329065262266
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.060215329065262266
ADAMS-OLIVER SYNDROME 2; AOS2	0.001843403	0.060215329065262266
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001843403	0.060215329065262266
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001843403	0.060215329065262266
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.001843403	0.060215329065262266
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001843403	0.060215329065262266
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001843403	0.060215329065262266
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001843403	0.060215329065262266
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001843403	0.060215329065262266
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001843403	0.060215329065262266
MONOSOMY 9P	0.001843403	0.060215329065262266
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001843403	0.060215329065262266
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.001843403	0.060215329065262266
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001843403	0.060215329065262266
EMANUEL SYNDROME	0.001843403	0.060215329065262266
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001843403	0.060215329065262266
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001843403	0.060215329065262266
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.060215329065262266
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001843403	0.060215329065262266
SSR4-CDG	0.001843403	0.060215329065262266
STT3B-CDG	0.001843403	0.060215329065262266
STT3A-CDG	0.001843403	0.060215329065262266
DISTAL TRISOMY 17Q	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001843403	0.060215329065262266
BOHRING-OPITZ SYNDROME	0.001843403	0.060215329065262266
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.060215329065262266
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.001843403	0.060215329065262266
DISTAL MONOSOMY 1Q	0.001843403	0.060215329065262266
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001843403	0.060215329065262266
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001843403	0.060215329065262266
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001843403	0.060215329065262266
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.001843403	0.060215329065262266
CHROMOSOME 10Q26 DELETION SYNDROME	0.001843403	0.060215329065262266
WIEACKER-WOLFF SYNDROME	0.001843403	0.060215329065262266
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001843403	0.060215329065262266
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001843403	0.060215329065262266
GLASS SYNDROME	0.001843403	0.060215329065262266
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001843403	0.060215329065262266
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001843403	0.060215329065262266
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001843403	0.060215329065262266
POTOCKI-LUPSKI SYNDROME	0.001843403	0.060215329065262266
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.001843403	0.060215329065262266
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001843403	0.060215329065262266
KOOLEN-DE VRIES SYNDROME; KDVS	0.001843403	0.060215329065262266
PHACE SYNDROME	0.001843403	0.060215329065262266
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001843403	0.060215329065262266
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.060215329065262266
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001843403	0.060215329065262266
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001843403	0.060215329065262266
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001843403	0.060215329065262266
PIERPONT SYNDROME	0.001843403	0.060215329065262266
AICARDI-GOUTIERES SYNDROME 7	0.001843403	0.060215329065262266
HOLOPROSENCEPHALY	0.001843403	0.060215329065262266
C SYNDROME	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001843403	0.060215329065262266
CONGENITAL TOXOPLASMOSIS	0.001843403	0.060215329065262266
RFT1-CDG	0.001843403	0.060215329065262266
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001843403	0.060215329065262266
COFFIN-SIRIS SYNDROME 1; CSS1	0.001843403	0.060215329065262266
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001843403	0.060215329065262266
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001843403	0.060215329065262266
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001843403	0.060215329065262266
GENITOPATELLAR SYNDROME	0.001843403	0.060215329065262266
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001843403	0.060215329065262266
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.060215329065262266
ALG1-CDG	0.001843403	0.060215329065262266
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001843403	0.060215329065262266
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001843403	0.060215329065262266
WALKER-WARBURG SYNDROME	0.001843403	0.060215329065262266
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001843403	0.060215329065262266
15Q24 MICRODELETION SYNDROME	0.001843403	0.060215329065262266
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001843403	0.060215329065262266
KOOLEN-DE VRIES SYNDROME	0.001843403	0.060215329065262266
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.060215329065262266
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001843403	0.060215329065262266
DUANE RETRACTION SYNDROME	0.001843403	0.060215329065262266
KBG SYNDROME	0.001843403	0.060215329065262266
EMANUEL SYNDROME	0.001843403	0.060215329065262266
KABUKI SYNDROME 1	0.001843403	0.060215329065262266
BOHRING-OPITZ SYNDROME	0.001843403	0.060215329065262266
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001843403	0.060215329065262266
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.060215329065262266
KBG SYNDROME	0.001843403	0.060215329065262266
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001843403	0.060215329065262266
MATERNAL PHENYLKETONURIA	0.001843403	0.060215329065262266
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.060215329065262266
ALG3-CDG	0.001843403	0.060215329065262266
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001843403	0.060215329065262266
INFANTILE LIVER FAILURE SYNDROME 1	0.001843403	0.060215329065262266
MACDERMOT-WINTER SYNDROME	0.001843403	0.060215329065262266
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001843403	0.060215329065262266
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.001843403	0.060215329065262266
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.060215329065262266
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001843403	0.060215329065262266
ADENYLOSUCCINASE DEFICIENCY	0.001843403	0.060215329065262266
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.060215329065262266
ADAMS-OLIVER SYNDROME 1; AOS1	0.001843403	0.060215329065262266
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001843403	0.060215329065262266
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001843403	0.060215329065262266
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001843403	0.060215329065262266
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.060215329065262266
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001843403	0.060215329065262266
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001843403	0.060215329065262266
CEDNIK SYNDROME	0.001843403	0.060215329065262266
XQ28 (MECP2) DUPLICATION	0.001843403	0.060215329065262266
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001843403	0.060215329065262266
CK SYNDROME	0.001843403	0.060215329065262266
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001843403	0.060215329065262266
VICI SYNDROME; VICIS	0.001843403	0.060215329065262266
3Q29 MICRODUPLICATION SYNDROME	0.001843403	0.060215329065262266
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001843403	0.060215329065262266
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.060215329065262266
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001843403	0.060215329065262266
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.060215329065262266
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.001843403	0.060215329065262266
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001843403	0.060215329065262266
MICRO SYNDROME	0.001843403	0.060215329065262266
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.060215329065262266
BARAITSER-WINTER SYNDROME 1; BRWS1	0.001843403	0.060215329065262266
8P23.1 MICRODELETION SYNDROME	0.001843403	0.060215329065262266
8P11.2 DELETION SYNDROME	0.001843403	0.060215329065262266
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001843403	0.060215329065262266
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.04252970999705784
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001301984	0.04252970999705784
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04252970999705784
MONOSOMY 13Q34	0.001301984	0.04252970999705784
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.001301984	0.04252970999705784
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001301984	0.04252970999705784
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04252970999705784
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001301984	0.04252970999705784
MOSAIC TRISOMY 9	0.001301984	0.04252970999705784
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.04252970999705784
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04252970999705784
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04252970999705784
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001301984	0.04252970999705784
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04252970999705784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.001301984	0.04252970999705784
LOWRY-MACLEAN SYNDROME	0.001301984	0.04252970999705784
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.001301984	0.04252970999705784
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001301984	0.04252970999705784
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04252970999705784
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.001301984	0.04252970999705784
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.001301984	0.04252970999705784
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.04252970999705784
BRESEK SYNDROME	0.001301984	0.04252970999705784
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04252970999705784
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.001301984	0.04252970999705784
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04252970999705784
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001301984	0.04252970999705784
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.001301984	0.04252970999705784
ROTHMUND-THOMSON SYNDROME	0.001301984	0.04252970999705784
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.04252970999705784
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.04252970999705784
RAINE SYNDROME	0.001301984	0.04252970999705784
OROFACIODIGITAL SYNDROME IX; OFD9	0.001301984	0.04252970999705784
MARINESCO-SJÖGREN SYNDROME	0.001301984	0.04252970999705784
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.04252970999705784
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001301984	0.04252970999705784
MUCOLIPIDOSIS IV; ML4	0.001301984	0.04252970999705784
MARINESCO-SJOGREN SYNDROME; MSS	0.001301984	0.04252970999705784
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.04252970999705784
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.04252970999705784
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001301984	0.04252970999705784
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.04252970999705784
OGDEN SYNDROME; OGDNS	0.001301984	0.04252970999705784
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.001301984	0.04252970999705784
HOLMES-GANG SYNDROME	0.001301984	0.04252970999705784
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04252970999705784
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04252970999705784
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.04252970999705784
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04252970999705784
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.001301984	0.04252970999705784
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.001301984	0.04252970999705784
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001301984	0.04252970999705784
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001301984	0.04252970999705784
BARATELA-SCOTT SYNDROME	0.001301984	0.04252970999705784
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.001301984	0.04252970999705784
MICROPHTHALMIA, SYNDROMIC 3	0.001301984	0.04252970999705784
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001301984	0.04252970999705784
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.001301984	0.04252970999705784
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.001301984	0.04252970999705784
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04252970999705784
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.04252970999705784
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001301984	0.04252970999705784
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04252970999705784
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.04252970999705784
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.001301984	0.04252970999705784
OKAMOTO SYNDROME	0.001301984	0.04252970999705784
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.001301984	0.04252970999705784
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.04252970999705784
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001301984	0.04252970999705784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.04252970999705784
SECKEL SYNDROME 9; SCKL9	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04252970999705784
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001301984	0.04252970999705784
OCULO-PALATO-CEREBRAL SYNDROME	0.001301984	0.04252970999705784
HOLOPROSENCEPHALY 11	0.001301984	0.04252970999705784
ALAZAMI-YUAN SYNDROME	0.001301984	0.04252970999705784
17P11.2 MICRODUPLICATION SYNDROME	0.001301984	0.04252970999705784
OROFACIODIGITAL SYNDROME TYPE 4	0.001301984	0.04252970999705784
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.001301984	0.04252970999705784
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001301984	0.04252970999705784
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04252970999705784
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.04252970999705784
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.04252970999705784
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04252970999705784
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04252970999705784
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.04252970999705784
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001301984	0.04252970999705784
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.001301984	0.04252970999705784
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.001301984	0.04252970999705784
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.04252970999705784
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.001301984	0.04252970999705784
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001301984	0.04252970999705784
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001301984	0.04252970999705784
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04252970999705784
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.001301984	0.04252970999705784
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04252970999705784
FETAL ALCOHOL SYNDROME	0.001301984	0.04252970999705784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001301984	0.04252970999705784
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.04252970999705784
MARDEN-WALKER SYNDROME	0.001301984	0.04252970999705784
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04252970999705784
FETAL HYDANTOIN SYNDROME	0.001301984	0.04252970999705784
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.001301984	0.04252970999705784
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04252970999705784
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001301984	0.04252970999705784
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.04252970999705784
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.04252970999705784
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04252970999705784
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.001301984	0.04252970999705784
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.04252970999705784
ALAZAMI SYNDROME; ALAZS	0.001301984	0.04252970999705784
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04252970999705784
8Q22.1 MICRODELETION SYNDROME	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.001301984	0.04252970999705784
ISOLATED COMPLEX I DEFICIENCY	0.001301984	0.04252970999705784
DYSTONIA 28, CHILDHOOD-ONSET	0.001301984	0.04252970999705784
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001301984	0.04252970999705784
OPTIC ATROPHY 11; OPA11	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04252970999705784
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.001301984	0.04252970999705784
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.04252970999705784
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.001301984	0.04252970999705784
MEVALONIC ACIDURIA; MEVA	0.001301984	0.04252970999705784
SAY-BARBER-MILLER SYNDROME	0.001301984	0.04252970999705784
AL-RAQAD SYNDROME; ARS	0.001301984	0.04252970999705784
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04252970999705784
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001301984	0.04252970999705784
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04252970999705784
DUPLICATION OF THE PITUITARY GLAND	0.001301984	0.04252970999705784
HOLOPROSENCEPHALY 5; HPE5	0.001301984	0.04252970999705784
CEREBROFACIOARTICULAR SYNDROME	0.001301984	0.04252970999705784
GOLDBERG-SHPRINTZEN SYNDROME	0.001301984	0.04252970999705784
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.001301984	0.04252970999705784
CRANIOSYNOSTOSIS 6; CRS6	0.001301984	0.04252970999705784
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.04252970999705784
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.04252970999705784
LIG4 SYNDROME	0.001301984	0.04252970999705784
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.04252970999705784
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.001301984	0.04252970999705784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.04252970999705784
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001301984	0.04252970999705784
GENITOPATELLAR SYNDROME; GTPTS	0.001301984	0.04252970999705784
RING CHROMOSOME 12 SYNDROME	0.001301984	0.04252970999705784
TRISOMY 18	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001301984	0.04252970999705784
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.001301984	0.04252970999705784
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.001301984	0.04252970999705784
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.001301984	0.04252970999705784
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04252970999705784
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.001301984	0.04252970999705784
AICARDI-GOUTIERES SYNDROME 5	0.001301984	0.04252970999705784
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04252970999705784
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.04252970999705784
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001301984	0.04252970999705784
MONOSOMY 18P	0.001301984	0.04252970999705784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04252970999705784
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.04252970999705784
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001301984	0.04252970999705784
HYPERTRICHOSIS CUBITI	0.001301984	0.04252970999705784
CONGENITAL VARICELLA SYNDROME	0.001301984	0.04252970999705784
HADZISELIMOVIC SYNDROME	0.001301984	0.04252970999705784
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04252970999705784
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.001301984	0.04252970999705784
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04252970999705784
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.04252970999705784
TOLUENE EMBRYOPATHY	0.001301984	0.04252970999705784
XERODERMA PIGMENTOSUM	0.001297849	0.042394638943313835
ZELLWEGER SYNDROME	0.001297849	0.042394638943313835
MOWAT-WILSON SYNDROME	0.001297849	0.042394638943313835
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.042394638943313835
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.001297849	0.042394638943313835
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.042394638943313835
KABUKI SYNDROME	0.001297849	0.042394638943313835
RENIER-GABREELS-JASPER SYNDROME	0.001297849	0.042394638943313835
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.001297849	0.042394638943313835
MEHMO SYNDROME	0.001297849	0.042394638943313835
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001297849	0.042394638943313835
SANJAD-SAKATI SYNDROME	0.001297849	0.042394638943313835
LOWRY-MACLEAN SYNDROME	0.001297849	0.042394638943313835
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.042394638943313835
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.001297849	0.042394638943313835
TRIPLE A SYNDROME	0.001297849	0.042394638943313835
HALL-RIGGS SYNDROME	0.001297849	0.042394638943313835
NON-DISTAL MONOSOMY 20Q	0.001297849	0.042394638943313835
HARROD SYNDROME	0.001297849	0.042394638943313835
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.042394638943313835
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.042394638943313835
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.042394638943313835
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001297849	0.042394638943313835
HEREDITARY METHEMOGLOBINEMIA	0.001297849	0.042394638943313835
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.042394638943313835
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.001297849	0.042394638943313835
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001297849	0.042394638943313835
ADENYLOSUCCINATE LYASE DEFICIENCY	0.001297849	0.042394638943313835
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.042394638943313835
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.001297849	0.042394638943313835
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001297849	0.042394638943313835
CONGENITAL RUBELLA SYNDROME	0.001297849	0.042394638943313835
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.042394638943313835
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.001297849	0.042394638943313835
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.042394638943313835
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.001297849	0.042394638943313835
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.042394638943313835
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.001297849	0.042394638943313835
KEPPEN-LUBINSKY SYNDROME	0.001297849	0.042394638943313835
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.042394638943313835
TEMPLE-BARAITSER SYNDROME	0.001297849	0.042394638943313835
20P13 MICRODELETION SYNDROME	0.001297849	0.042394638943313835
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.001297849	0.042394638943313835
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.001297849	0.042394638943313835
COFS SYNDROME	0.001297849	0.042394638943313835
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.001297849	0.042394638943313835
WORSTER-DROUGHT SYNDROME	0.001297849	0.042394638943313835
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.001297849	0.042394638943313835
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.042394638943313835
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.001297849	0.042394638943313835
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.042394638943313835
CAMOS SYNDROME	0.001297849	0.042394638943313835
SJÖGREN-LARSSON SYNDROME	0.001297849	0.042394638943313835
DPM1-CDG	0.001297849	0.042394638943313835
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.001297849	0.042394638943313835
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.042394638943313835
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.001297849	0.042394638943313835
ANGELMAN SYNDROME	0.001297849	0.042394638943313835
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001297849	0.042394638943313835
PRIMARY CUTIS VERTICIS GYRATA	0.001297849	0.042394638943313835
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.042394638943313835
MOYNAHAN SYNDROME	0.001297849	0.042394638943313835
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.042394638943313835
NORRIE DISEASE	0.001297849	0.042394638943313835
NEVUS COMEDONICUS SYNDROME	0.001297849	0.042394638943313835
14Q12 MICRODELETION SYNDROME	0.001297849	0.042394638943313835
21Q22.11Q22.12 MICRODELETION SYNDROME	0.001297849	0.042394638943313835
COG5-CDG	0.001297849	0.042394638943313835
MENKES DISEASE	0.001297849	0.042394638943313835
DISTAL TRISOMY 15Q	0.001297849	0.042394638943313835
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.042394638943313835
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.042394638943313835
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.042394638943313835
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.042394638943313835
LISSENCEPHALY 3; LIS3	0.001297849	0.042394638943313835
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.042394638943313835
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.001297849	0.042394638943313835
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.042394638943313835
MARDEN-WALKER SYNDROME	0.001297849	0.042394638943313835
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.001297849	0.042394638943313835
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.001297849	0.042394638943313835
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.001297849	0.042394638943313835
BANGSTAD SYNDROME	0.001297849	0.042394638943313835
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.042394638943313835
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.042394638943313835
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.001297849	0.042394638943313835
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.001297849	0.042394638943313835
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.042394638943313835
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.042394638943313835
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001297849	0.042394638943313835
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.001297849	0.042394638943313835
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.001297849	0.042394638943313835
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.042394638943313835
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.042394638943313835
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001297849	0.042394638943313835
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.042394638943313835
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.001297849	0.042394638943313835
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.001297849	0.042394638943313835
PITT-HOPKINS SYNDROME	0.001297849	0.042394638943313835
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001297849	0.042394638943313835
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001297849	0.042394638943313835
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.001297849	0.042394638943313835
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.042394638943313835
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.042394638943313835
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.042394638943313835
KLEEFSTRA SYNDROME	0.001297849	0.042394638943313835
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.042394638943313835
ASPARTYLGLUCOSAMINURIA; AGU	0.001297849	0.042394638943313835
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001297849	0.042394638943313835
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.042394638943313835
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001297849	0.042394638943313835
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.042394638943313835
MENTAL RETARDATION, X-LINKED 102	0.001297849	0.042394638943313835
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.001297849	0.042394638943313835
XYLOSIDASE DEFICIENCY	0.001297849	0.042394638943313835
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001297849	0.042394638943313835
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001297849	0.042394638943313835
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001297849	0.042394638943313835
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001297849	0.042394638943313835
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.042394638943313835
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.042394638943313835
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.001297849	0.042394638943313835
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.001297849	0.042394638943313835
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.001297849	0.042394638943313835
PSEUDO-TORCH SYNDROME 2	0.001297849	0.042394638943313835
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001297849	0.042394638943313835
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.042394638943313835
MOWAT-WILSON SYNDROME; MOWS	0.001297849	0.042394638943313835
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.042394638943313835
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.001297849	0.042394638943313835
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.001297849	0.042394638943313835
KEARNS-SAYRE SYNDROME; KSS	0.001297849	0.042394638943313835
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001297849	0.042394638943313835
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.001297849	0.042394638943313835
OROFACIODIGITAL SYNDROME I; OFD1	0.001297849	0.042394638943313835
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.001297849	0.042394638943313835
PHENYLKETONURIA	0.001297849	0.042394638943313835
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001297849	0.042394638943313835
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.042394638943313835
MICROPHTHALMIA, SYNDROMIC 1	0.001297849	0.042394638943313835
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.001297849	0.042394638943313835
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.042394638943313835
INCONTINENTIA PIGMENTI; IP	0.001297849	0.042394638943313835
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.042394638943313835
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.001297849	0.042394638943313835
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.001297849	0.042394638943313835
PERRAULT SYNDROME 3	0.001297849	0.042394638943313835
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001297849	0.042394638943313835
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.042394638943313835
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.042394638943313835
COHEN SYNDROME	0.001297849	0.042394638943313835
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.001297849	0.042394638943313835
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.001297849	0.042394638943313835
LATHOSTEROLOSIS	0.001297849	0.042394638943313835
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.001297849	0.042394638943313835
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.042394638943313835
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.001297849	0.042394638943313835
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.042394638943313835
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.042394638943313835
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.042394638943313835
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.042394638943313835
FILIPPI SYNDROME; FLPIS	0.001297849	0.042394638943313835
SECKEL SYNDROME 7; SCKL7	0.001297849	0.042394638943313835
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.042394638943313835
GAUCHER DISEASE, PERINATAL LETHAL	0.001297849	0.042394638943313835
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001297849	0.042394638943313835
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.042394638943313835
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.001297849	0.042394638943313835
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.042394638943313835
COFFIN-LOWRY SYNDROME; CLS	0.001297849	0.042394638943313835
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.001297849	0.042394638943313835
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.001297849	0.042394638943313835
CYCLIC VOMITING SYNDROME	0.001297849	0.042394638943313835
CROME SYNDROME	0.001297849	0.042394638943313835
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03550630919015284
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03550630919015284
6Q TERMINAL DELETION SYNDROME	0.001086973	0.03550630919015284
DONNAI-BARROW SYNDROME	0.001086973	0.03550630919015284
INFANTILE REFSUM DISEASE	0.001086973	0.03550630919015284
MONOSOMY 9Q22.3	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03550630919015284
HARTNUP DISORDER	0.001086973	0.03550630919015284
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.03550630919015284
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.03550630919015284
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03550630919015284
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03550630919015284
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.03550630919015284
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03550630919015284
HARTNUP DISEASE	0.001086973	0.03550630919015284
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03550630919015284
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03550630919015284
OPTIC PATHWAY GLIOMA	0.001086973	0.03550630919015284
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03550630919015284
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.03550630919015284
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03550630919015284
PETTIGREW SYNDROME	0.001086973	0.03550630919015284
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.03550630919015284
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.03550630919015284
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.03550630919015284
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03550630919015284
TAY-SACHS DISEASE	0.001086973	0.03550630919015284
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.03550630919015284
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03550630919015284
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03550630919015284
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.001086973	0.03550630919015284
KEUTEL SYNDROME	0.001086973	0.03550630919015284
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03550630919015284
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.03550630919015284
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.03550630919015284
DYSTONIA-APHONIA SYNDROME	0.001086973	0.03550630919015284
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.03550630919015284
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.03550630919015284
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03550630919015284
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03550630919015284
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03550630919015284
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03550630919015284
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03550630919015284
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03550630919015284
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03550630919015284
PMM2-CDG	0.001086973	0.03550630919015284
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03550630919015284
GAUCHER DISEASE, TYPE II	0.001086973	0.03550630919015284
DESANTO-SHINAWI SYNDROME	0.001086973	0.03550630919015284
COWDEN SYNDROME	0.001086973	0.03550630919015284
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.03550630919015284
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.03550630919015284
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03550630919015284
EAST SYNDROME	0.001086973	0.03550630919015284
XQ25 DUPLICATION SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03550630919015284
SCHIZENCEPHALY	0.001086973	0.03550630919015284
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.001086973	0.03550630919015284
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03550630919015284
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.03550630919015284
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.03550630919015284
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03550630919015284
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.03550630919015284
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03550630919015284
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03550630919015284
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03550630919015284
WYBURN-MASON SYNDROME	0.001086973	0.03550630919015284
CRANIOPHARYNGIOMA	0.001086973	0.03550630919015284
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.03550630919015284
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.03550630919015284
LEIGH SYNDROME; LS	0.001086973	0.03550630919015284
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.03550630919015284
ELEJALDE DISEASE	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.03550630919015284
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03550630919015284
17Q12 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03550630919015284
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.03550630919015284
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.03550630919015284
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03550630919015284
SULFOCYSTEINURIA	0.001086973	0.03550630919015284
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001086973	0.03550630919015284
SCHAAF-YANG SYNDROME; SHFYNG	0.001086973	0.03550630919015284
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.03550630919015284
KAGAMI-OGATA SYNDROME	0.001086973	0.03550630919015284
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03550630919015284
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03550630919015284
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03550630919015284
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03550630919015284
INFANTILE SIALIC ACID STORAGE DISEASE	0.001086973	0.03550630919015284
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03550630919015284
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03550630919015284
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03550630919015284
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03550630919015284
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03550630919015284
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03550630919015284
MAPLE SYRUP URINE DISEASE	0.001086973	0.03550630919015284
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03550630919015284
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.03550630919015284
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001086973	0.03550630919015284
1Q21.1 MICRODUPLICATION SYNDROME	0.001086973	0.03550630919015284
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.03550630919015284
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.03550630919015284
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.001086973	0.03550630919015284
PEHO SYNDROME; PEHO	0.001086973	0.03550630919015284
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.03550630919015284
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.03550630919015284
20P12.3 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.001086973	0.03550630919015284
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.03550630919015284
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03550630919015284
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03550630919015284
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001086973	0.03550630919015284
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03550630919015284
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03550630919015284
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03550630919015284
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03550630919015284
LANDAU-KLEFFNER SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03550630919015284
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03550630919015284
KETOADIPICACIDURIA	0.001086973	0.03550630919015284
HYDRANENCEPHALY	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.03550630919015284
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.03550630919015284
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.03550630919015284
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.03550630919015284
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.03550630919015284
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.03550630919015284
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.03550630919015284
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03550630919015284
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.03550630919015284
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03550630919015284
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.03550630919015284
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03550630919015284
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.03550630919015284
XP21 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.001086973	0.03550630919015284
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.03550630919015284
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001086973	0.03550630919015284
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03550630919015284
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03550630919015284
NETHERTON SYNDROME	0.001086973	0.03550630919015284
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03550630919015284
JACOBSEN SYNDROME	0.001086973	0.03550630919015284
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.03550630919015284
WEAVER SYNDROME	0.001086973	0.03550630919015284
ALSTRÖM SYNDROME	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.03550630919015284
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001086973	0.03550630919015284
NARP SYNDROME	0.001086973	0.03550630919015284
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03550630919015284
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03550630919015284
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03550630919015284
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.03550630919015284
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03550630919015284
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.03550630919015284
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03550630919015284
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03550630919015284
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03550630919015284
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03550630919015284
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.03550630919015284
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.03550630919015284
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03550630919015284
DISTAL MONOSOMY 19P13.3	0.001086973	0.03550630919015284
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.03550630919015284
SEVERE CANAVAN DISEASE	0.001086973	0.03550630919015284
SOTOS SYNDROME	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03550630919015284
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.03550630919015284
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03550630919015284
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03550630919015284
SCHINDLER DISEASE, TYPE I	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03550630919015284
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.03550630919015284
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03550630919015284
19P13.13 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.03550630919015284
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03550630919015284
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.03550630919015284
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.03550630919015284
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03550630919015284
TIMOTHY SYNDROME; TS	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.03550630919015284
CANAVAN DISEASE	0.001086973	0.03550630919015284
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.03550630919015284
DIGEORGE SYNDROME; DGS	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.03550630919015284
FG SYNDROME TYPE 1	0.001086973	0.03550630919015284
SMITH-MAGENIS SYNDROME; SMS	0.001086973	0.03550630919015284
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03550630919015284
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03550630919015284
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.03550630919015284
HOLOPROSENCEPHALY 7	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.03550630919015284
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03550630919015284
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03550630919015284
PRADER-WILLI SYNDROME; PWS	0.001086973	0.03550630919015284
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.03550630919015284
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.03550630919015284
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001086973	0.03550630919015284
MUENKE SYNDROME	0.001086973	0.03550630919015284
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.03550630919015284
PROPIONIC ACIDEMIA	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.03550630919015284
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03550630919015284
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03550630919015284
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.03550630919015284
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03550630919015284
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.03550630919015284
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.03550630919015284
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03550630919015284
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.03550630919015284
LISSENCEPHALY 1; LIS1	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.001086973	0.03550630919015284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.03550630919015284
ISOVALERIC ACIDEMIA	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03550630919015284
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.03550630919015284
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03550630919015284
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.03550630919015284
POTOCKI-SHAFFER SYNDROME	0.001086973	0.03550630919015284
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03550630919015284
PHACE ASSOCIATION	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.03550630919015284
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03550630919015284
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.03550630919015284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03550630919015284
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.03550630919015284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03550630919015284
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.03550630919015284
PALLISTER-HALL SYNDROME	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03550630919015284
SALLA DISEASE	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03550630919015284
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03550630919015284
FUCOSIDOSIS	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03550630919015284
WILSON-TURNER SYNDROME	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.03550630919015284
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.03550630919015284
KAGAMI-OGATA SYNDROME	0.001086973	0.03550630919015284
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.03550630919015284
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03550630919015284
SRD5A3-CDG	0.001086973	0.03550630919015284
XQ21 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03550630919015284
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03550630919015284
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03550630919015284
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03550630919015284
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03550630919015284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03550630919015284
ARGININEMIA	0.001086973	0.03550630919015284
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.03550630919015284
OCULOECTODERMAL SYNDROME; OES	0.001086973	0.03550630919015284
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03550630919015284
BAND HETEROTOPIA; BH	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.03550630919015284
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03550630919015284
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03550630919015284
MOSAIC TRISOMY 14	0.001086973	0.03550630919015284
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03550630919015284
ZTTK SYNDROME; ZTTKS	0.001086973	0.03550630919015284
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.03550630919015284
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03550630919015284
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.03550630919015284
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.03550630919015284
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03550630919015284
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.03550630919015284
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.03550630919015284
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.03550630919015284
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03550630919015284
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03550630919015284
PRADER-WILLI-LIKE SYNDROME	0.001086973	0.03550630919015284
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001086973	0.03550630919015284
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.001086973	0.03550630919015284
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03550630919015284
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03550630919015284
2P21 MICRODELETION SYNDROME	0.001086973	0.03550630919015284
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03550630919015284
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03550630919015284
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.03550630919015284
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03550630919015284
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03550630919015284
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03550630919015284
TARP SYNDROME	0.001086973	0.03550630919015284
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.03550630919015284
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.03550630919015284
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03550630919015284
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03550630919015284
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03550630919015284
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.03550630919015284
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.03550630919015284
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03550630919015284
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.03550630919015284
CITRULLINEMIA, CLASSIC	0.001086973	0.03550630919015284
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.03550630919015284
VICI SYNDROME	0.001086973	0.03550630919015284
MIRAGE SYNDROME; MIRAGE	0.001086973	0.03550630919015284
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.03550630919015284
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03550630919015284
GRISCELLI SYNDROME	0.001086973	0.03550630919015284
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.03550630919015284
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03550630919015284
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.03550630919015284
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03550630919015284
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03550630919015284
COACH SYNDROME	0.001086973	0.03550630919015284
CODAS SYNDROME	0.001086973	0.03550630919015284
611961 STEVENSON-CAREY SYNDROME	0.001086973	0.03550630919015284
XK APROSENCEPHALY SYNDROME	0.00075643	0.024709019875109418
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.024709019875109418
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00075643	0.024709019875109418
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00075643	0.024709019875109418
WEAVER-WILLIAMS SYNDROME	0.00075643	0.024709019875109418
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.024709019875109418
ROBERTS SYNDROME; RBS	0.00075643	0.024709019875109418
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.024709019875109418
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.024709019875109418
TEEBI-SHALTOUT SYNDROME; TBSH	0.00075643	0.024709019875109418
RHIZOMELIC SYNDROME	0.00075643	0.024709019875109418
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.024709019875109418
PIEBALDISM	0.00075643	0.024709019875109418
TETRAPLOIDY	0.00075643	0.024709019875109418
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.024709019875109418
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.024709019875109418
MMEP SYNDROME	0.00075643	0.024709019875109418
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.024709019875109418
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.024709019875109418
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00075643	0.024709019875109418
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.024709019875109418
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.00075643	0.024709019875109418
FOCAL DERMAL HYPOPLASIA; FDH	0.00075643	0.024709019875109418
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.024709019875109418
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00075643	0.024709019875109418
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.024709019875109418
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.00075643	0.024709019875109418
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.024709019875109418
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00075643	0.024709019875109418
MASA SYNDROME	0.00075643	0.024709019875109418
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.024709019875109418
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.00075643	0.024709019875109418
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.024709019875109418
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.024709019875109418
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00075643	0.024709019875109418
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.024709019875109418
FACIOCARDIOMELIC SYNDROME	0.00075643	0.024709019875109418
FAMILIAL VISCERAL MYOPATHY	0.00075643	0.024709019875109418
POLAND SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00075643	0.024709019875109418
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.024709019875109418
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.024709019875109418
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.024709019875109418
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.024709019875109418
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.024709019875109418
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.024709019875109418
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.024709019875109418
MEIER-GORLIN SYNDROME 2; MGORS2	0.00075643	0.024709019875109418
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.024709019875109418
NEU-LAXOVA SYNDROME	0.00075643	0.024709019875109418
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.024709019875109418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.024709019875109418
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.024709019875109418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00075643	0.024709019875109418
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00075643	0.024709019875109418
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.024709019875109418
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00075643	0.024709019875109418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.024709019875109418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.024709019875109418
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.024709019875109418
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.024709019875109418
RENAL TUBULAR DYSGENESIS	0.00075643	0.024709019875109418
XFE PROGEROID SYNDROME; XFEPS	0.00075643	0.024709019875109418
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00075643	0.024709019875109418
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.00075643	0.024709019875109418
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.024709019875109418
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00075643	0.024709019875109418
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00075643	0.024709019875109418
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00075643	0.024709019875109418
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00075643	0.024709019875109418
ALLAN-HERNDON-DUDLEY SYNDROME	0.00075643	0.024709019875109418
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00075643	0.024709019875109418
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.024709019875109418
XYLT1-CDG	0.00075643	0.024709019875109418
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00075643	0.024709019875109418
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.024709019875109418
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00075643	0.024709019875109418
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.024709019875109418
ACROOTOOCULAR SYNDROME	0.00075643	0.024709019875109418
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.024709019875109418
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.024709019875109418
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00075643	0.024709019875109418
MONOSOMY 5P	0.00075643	0.024709019875109418
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.024709019875109418
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.024709019875109418
STIMMLER SYNDROME	0.00075643	0.024709019875109418
SECKEL SYNDROME 4	0.00075643	0.024709019875109418
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00075643	0.024709019875109418
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.024709019875109418
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.00075643	0.024709019875109418
ERYTHROKERATODERMIA VARIABILIS	0.00075643	0.024709019875109418
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00075643	0.024709019875109418
WARBURG MICRO SYNDROME 1	0.00075643	0.024709019875109418
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00075643	0.024709019875109418
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.024709019875109418
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.024709019875109418
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.024709019875109418
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.024709019875109418
PSEUDOPROGERIA SYNDROME	0.00075643	0.024709019875109418
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00075643	0.024709019875109418
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00075643	0.024709019875109418
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00075643	0.024709019875109418
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.024709019875109418
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00075643	0.024709019875109418
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00075643	0.024709019875109418
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.024709019875109418
DE SANCTIS-CACCHIONE SYNDROME	0.00075643	0.024709019875109418
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.024709019875109418
SATOYOSHI SYNDROME	0.00075643	0.024709019875109418
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00075643	0.024709019875109418
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.024709019875109418
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00075643	0.024709019875109418
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.024709019875109418
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00075643	0.024709019875109418
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.024709019875109418
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00075643	0.024709019875109418
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.024709019875109418
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.024709019875109418
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.024709019875109418
MARTSOLF SYNDROME	0.00075643	0.024709019875109418
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.024709019875109418
NON-DISTAL TRISOMY 10Q	0.00075643	0.024709019875109418
NON-DISTAL TRISOMY 13Q	0.00075643	0.024709019875109418
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.024709019875109418
SECKEL SYNDROME 10; SCKL10	0.00075643	0.024709019875109418
DISTAL MONOSOMY 17Q	0.00075643	0.024709019875109418
DISTAL MONOSOMY 13Q	0.00075643	0.024709019875109418
WAGR SYNDROME	0.00075643	0.024709019875109418
WAARDENBURG SYNDROME TYPE 3	0.00075643	0.024709019875109418
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.024709019875109418
ANE SYNDROME	0.00075643	0.024709019875109418
KLIPPEL-TRÉNAUNAY SYNDROME	0.00075643	0.024709019875109418
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.024709019875109418
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00075643	0.024709019875109418
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.024709019875109418
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.024709019875109418
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00075643	0.024709019875109418
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.024709019875109418
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.024709019875109418
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00075643	0.024709019875109418
TRISOMY 18P	0.00075643	0.024709019875109418
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.024709019875109418
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.024709019875109418
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.024709019875109418
FANCONI ANEMIA	0.00075643	0.024709019875109418
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00075643	0.024709019875109418
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.024709019875109418
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.024709019875109418
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.024709019875109418
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.024709019875109418
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00075643	0.024709019875109418
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.024709019875109418
DIABETIC EMBRYOPATHY	0.00075643	0.024709019875109418
FETAL METHYLMERCURY SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00075643	0.024709019875109418
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00075643	0.024709019875109418
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.024709019875109418
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00075643	0.024709019875109418
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00075643	0.024709019875109418
BARDET-BIEDL SYNDROME 20	0.00075643	0.024709019875109418
SEVERE COMBINED IMMUNODEFICIENCY	0.00075643	0.024709019875109418
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.024709019875109418
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.024709019875109418
LOWRY-WOOD SYNDROME	0.00075643	0.024709019875109418
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00075643	0.024709019875109418
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.024709019875109418
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.024709019875109418
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00075643	0.024709019875109418
YUNIS-VARON SYNDROME	0.00075643	0.024709019875109418
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00075643	0.024709019875109418
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.024709019875109418
CHARGE SYNDROME	0.00075643	0.024709019875109418
TRISOMY 4P	0.00075643	0.024709019875109418
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00075643	0.024709019875109418
ADDUCTED THUMBS SYNDROME	0.00075643	0.024709019875109418
RING CHROMOSOME 6 SYNDROME	0.00075643	0.024709019875109418
GERODERMA OSTEODYSPLASTICUM; GO	0.00075643	0.024709019875109418
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.024709019875109418
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.00075643	0.024709019875109418
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.024709019875109418
CRI-DU-CHAT SYNDROME	0.00075643	0.024709019875109418
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.024709019875109418
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00075643	0.024709019875109418
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.024709019875109418
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00075643	0.024709019875109418
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.024709019875109418
HYPERREFLEXIA	0.00075643	0.024709019875109418
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.024709019875109418
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.024709019875109418
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00075643	0.024709019875109418
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.024709019875109418
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.024709019875109418
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.024709019875109418
PAGOD SYNDROME	0.00075643	0.024709019875109418
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.024709019875109418
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.024709019875109418
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.024709019875109418
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.024709019875109418
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.024709019875109418
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00075643	0.024709019875109418
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00075643	0.024709019875109418
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00075643	0.024709019875109418
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00075643	0.024709019875109418
2P15-16.1 MICRODELETION SYNDROME	0.00075643	0.024709019875109418
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.024709019875109418
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.024709019875109418
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.024709019875109418
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00075643	0.024709019875109418
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.024709019875109418
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.024709019875109418
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00075643	0.024709019875109418
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.024709019875109418
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00075643	0.024709019875109418
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.024709019875109418
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.024709019875109418
VELOCARDIOFACIAL SYNDROME	0.00075643	0.024709019875109418
OTOMANDIBULAR SYNDROME	0.00075643	0.024709019875109418
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.024709019875109418
SAY SYNDROME	0.00075643	0.024709019875109418
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00075643	0.024709019875109418
RUVALCABA SYNDROME	0.00075643	0.024709019875109418
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00075643	0.024709019875109418
CAREY-FINEMAN-ZITER SYNDROME	0.00075643	0.024709019875109418
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.024709019875109418
ACROCRANIOFACIAL DYSOSTOSIS	0.00075643	0.024709019875109418
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.024709019875109418
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.024709019875109418
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00075643	0.024709019875109418
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.024709019875109418
BLOOM SYNDROME	0.00075643	0.024709019875109418
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.024709019875109418
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00075643	0.024709019875109418
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.024709019875109418
DISTAL TRISOMY 5Q	0.00075643	0.024709019875109418
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.024709019875109418
ATAXIA-PANCYTOPENIA SYNDROME	0.00075643	0.024709019875109418
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00075643	0.024709019875109418
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.024709019875109418
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00075643	0.024709019875109418
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.024709019875109418
RING CHROMOSOME 13 SYNDROME	0.00075643	0.024709019875109418
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00075643	0.024709019875109418
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.024709019875109418
JOHANSON-BLIZZARD SYNDROME	0.00075643	0.024709019875109418
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.024709019875109418
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.024709019875109418
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.024709019875109418
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.024709019875109418
JUNG SYNDROME	0.00075643	0.024709019875109418
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.024709019875109418
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.024709019875109418
ISOTRETINOIN-LIKE SYNDROME	0.00075643	0.024709019875109418
SCHISIS ASSOCIATION	0.00075643	0.024709019875109418
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.024709019875109418
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.024709019875109418
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.024709019875109418
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.024709019875109418
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00075643	0.024709019875109418
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.024709019875109418
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00075643	0.024709019875109418
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.024709019875109418
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.024709019875109418
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.024709019875109418
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.024709019875109418
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00075643	0.024709019875109418
MECKEL SYNDROME 12; MKS12	0.00075643	0.024709019875109418
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.024709019875109418
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.024709019875109418
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00075643	0.024709019875109418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.024709019875109418
MECKEL SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00075643	0.024709019875109418
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.024709019875109418
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00075643	0.024709019875109418
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.024709019875109418
LEPRECHAUNISM	0.00075643	0.024709019875109418
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.024709019875109418
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00075643	0.024709019875109418
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.024709019875109418
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00075643	0.024709019875109418
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.024709019875109418
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.024709019875109418
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00075643	0.024709019875109418
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00075643	0.024709019875109418
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00075643	0.024709019875109418
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.024709019875109418
SHPRINTZEN-GOLDBERG SYNDROME	0.00075643	0.024709019875109418
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.024709019875109418
46,XX GONADAL DYSGENESIS	0.00075643	0.024709019875109418
LAMBOTTE SYNDROME	0.00075643	0.024709019875109418
JUBERG-HAYWARD SYNDROME	0.00075643	0.024709019875109418
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00075643	0.024709019875109418
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.024709019875109418
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00075643	0.024709019875109418
GMS SYNDROME	0.00075643	0.024709019875109418
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00075643	0.024709019875109418
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.024709019875109418
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.024709019875109418
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.024709019875109418
FRASER SYNDROME	0.00075643	0.024709019875109418
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.024709019875109418
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.024709019875109418
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.024709019875109418
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.024709019875109418
STROMME SYNDROME; STROMS	0.00075643	0.024709019875109418
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.024709019875109418
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.024709019875109418
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.024709019875109418
ISOLATED PLAGIOCEPHALY	0.000545554	0.017820690121948424
SYNDROMIC DIARRHEA	0.000545554	0.017820690121948424
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.017820690121948424
PELLAGRA-LIKE SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.017820690121948424
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.017820690121948424
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.017820690121948424
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.017820690121948424
EPIDERMAL NEVUS SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.017820690121948424
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.017820690121948424
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.017820690121948424
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.017820690121948424
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.017820690121948424
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.017820690121948424
RIGID SPINE SYNDROME	0.000545554	0.017820690121948424
NAVAJO NEUROHEPATOPATHY	0.000545554	0.017820690121948424
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.000545554	0.017820690121948424
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.017820690121948424
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.017820690121948424
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.017820690121948424
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.017820690121948424
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.017820690121948424
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.017820690121948424
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.017820690121948424
CDAGS SYNDROME	0.000545554	0.017820690121948424
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.017820690121948424
TRANSKETOLASE DEFICIENCY	0.000545554	0.017820690121948424
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.017820690121948424
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.017820690121948424
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.017820690121948424
OROTIC ACIDURIA	0.000545554	0.017820690121948424
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.017820690121948424
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.017820690121948424
ZEBRA BODY MYOPATHY	0.000545554	0.017820690121948424
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.017820690121948424
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.017820690121948424
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.017820690121948424
8P23.1 DUPLICATION SYNDROME	0.000545554	0.017820690121948424
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.017820690121948424
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.017820690121948424
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.017820690121948424
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.017820690121948424
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.017820690121948424
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.017820690121948424
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.017820690121948424
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.017820690121948424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.017820690121948424
REVESZ SYNDROME	0.000545554	0.017820690121948424
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.017820690121948424
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.017820690121948424
FARBER DISEASE	0.000545554	0.017820690121948424
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.017820690121948424
CONGENITAL HYPOTHYROIDISM	0.000545554	0.017820690121948424
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.017820690121948424
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.017820690121948424
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.017820690121948424
3MC SYNDROME 2	0.000545554	0.017820690121948424
PROPIONIC ACIDEMIA	0.000545554	0.017820690121948424
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.017820690121948424
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.017820690121948424
YUNIS-VARON SYNDROME	0.000545554	0.017820690121948424
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.017820690121948424
COSTELLO SYNDROME; CSTLO	0.000545554	0.017820690121948424
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.017820690121948424
NOONAN SYNDROME 2; NS2	0.000545554	0.017820690121948424
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.017820690121948424
FRONTOOCULAR SYNDROME	0.000545554	0.017820690121948424
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.017820690121948424
48,XYYY SYNDROME	0.000545554	0.017820690121948424
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.017820690121948424
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.017820690121948424
WEAVER SYNDROME	0.000545554	0.017820690121948424
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.017820690121948424
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.017820690121948424
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.017820690121948424
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.017820690121948424
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.017820690121948424
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.017820690121948424
HYDROXYKYNURENINURIA	0.000545554	0.017820690121948424
CURRY-JONES SYNDROME	0.000545554	0.017820690121948424
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.017820690121948424
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.017820690121948424
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.017820690121948424
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
AUSTRALIA ANTIGEN	0.000545554	0.017820690121948424
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.017820690121948424
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.017820690121948424
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.017820690121948424
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.017820690121948424
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.017820690121948424
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.017820690121948424
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.017820690121948424
JOUBERT SYNDROME 10	0.000545554	0.017820690121948424
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.017820690121948424
ALSTROM SYNDROME; ALMS	0.000545554	0.017820690121948424
RABSON-MENDENHALL SYNDROME	0.000545554	0.017820690121948424
JAWAD SYNDROME	0.000545554	0.017820690121948424
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.017820690121948424
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.017820690121948424
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.017820690121948424
3C SYNDROME	0.000545554	0.017820690121948424
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.017820690121948424
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.017820690121948424
TARP SYNDROME; TARPS	0.000545554	0.017820690121948424
JOUBERT SYNDROME 1	0.000545554	0.017820690121948424
TREACHER-COLLINS SYNDROME	0.000545554	0.017820690121948424
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.017820690121948424
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.017820690121948424
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.000545554	0.017820690121948424
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.017820690121948424
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.017820690121948424
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.017820690121948424
300270 ADRENOMYODYSTROPHY	0.000545554	0.017820690121948424
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.017820690121948424
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.017820690121948424
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.017820690121948424
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.017820690121948424
WOLMAN DISEASE	0.000545554	0.017820690121948424
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.017820690121948424
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.017820690121948424
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.017820690121948424
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.017820690121948424
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.017820690121948424
OROFACIODIGITAL SYNDROME VI	0.000545554	0.017820690121948424
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.017820690121948424
THYROID ECTOPIA	0.000545554	0.017820690121948424
ATHYREOSIS	0.000545554	0.017820690121948424
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.017820690121948424
HYDROXYKYNURENINURIA	0.000545554	0.017820690121948424
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.017820690121948424
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.017820690121948424
ALPHA-MANNOSIDOSIS	0.000545554	0.017820690121948424
NETHERTON SYNDROME; NETH	0.000545554	0.017820690121948424
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.017820690121948424
THYROID HEMIAGENESIS	0.000545554	0.017820690121948424
ARIMA SYNDROME	0.000545554	0.017820690121948424
THYROID HYPOPLASIA	0.000545554	0.017820690121948424
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.017820690121948424
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.017820690121948424
ATELOSTEOGENESIS TYPE III	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.017820690121948424
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.017820690121948424
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.017820690121948424
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.017820690121948424
WAARDENBURG-SHAH SYNDROME	0.000545554	0.017820690121948424
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.017820690121948424
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.017820690121948424
HURLER SYNDROME	0.000545554	0.017820690121948424
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.017820690121948424
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.017820690121948424
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.017820690121948424
HURLER SYNDROME	0.000545554	0.017820690121948424
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.017820690121948424
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.017820690121948424
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.000545554	0.017820690121948424
SEPTOOPTIC DYSPLASIA	0.000545554	0.017820690121948424
ALG6-CDG	0.000545554	0.017820690121948424
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.017820690121948424
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.017820690121948424
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.017820690121948424
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.017820690121948424
CURRARINO SYNDROME	0.000545554	0.017820690121948424
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.017820690121948424
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.017820690121948424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.017820690121948424
ICF SYNDROME	0.000545554	0.017820690121948424
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.017820690121948424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.017820690121948424
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.017820690121948424
8Q12 MICRODUPLICATION SYNDROME	0.000545554	0.017820690121948424
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.017820690121948424
MICROVILLUS INCLUSION DISEASE	0.000545554	0.017820690121948424
USHER SYNDROME TYPE 1	0.000545554	0.017820690121948424
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.017820690121948424
PERIPHERAL HYPOTHYROIDISM	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.017820690121948424
BARDET-BIEDL SYNDROME 2	0.000545554	0.017820690121948424
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.017820690121948424
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.017820690121948424
CULLER-JONES SYNDROME; CJS	0.000545554	0.017820690121948424
XIA-GIBBS SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.017820690121948424
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.000545554	0.017820690121948424
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.017820690121948424
ZECHI-CEIDE SYNDROME	0.000545554	0.017820690121948424
GERODERMA OSTEODYSPLASTICA	0.000545554	0.017820690121948424
AU-KLINE SYNDROME; AUKS	0.000545554	0.017820690121948424
NOONAN SYNDROME 9; NS9	0.000545554	0.017820690121948424
CUTIS LAXA	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.017820690121948424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.017820690121948424
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.017820690121948424
CHOPS SYNDROME; CHOPS	0.000545554	0.017820690121948424
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.017820690121948424
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.017820690121948424
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.017820690121948424
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.017820690121948424
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.017820690121948424
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.017820690121948424
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.017820690121948424
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.017820690121948424
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.017820690121948424
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.017820690121948424
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.017820690121948424
SENIOR-LOKEN SYNDROME 9	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.017820690121948424
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.017820690121948424
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.017820690121948424
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.017820690121948424
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.017820690121948424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.017820690121948424
JOUBERT SYNDROME 15	0.000545554	0.017820690121948424
JOUBERT SYNDROME 14	0.000545554	0.017820690121948424
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.017820690121948424
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.017820690121948424
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.017820690121948424
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.017820690121948424
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.017820690121948424
OPITZ G/BBB SYNDROME	0.000545554	0.017820690121948424
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.017820690121948424
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.017820690121948424
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.017820690121948424
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.017820690121948424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.017820690121948424
OGDEN SYNDROME	0.000545554	0.017820690121948424
CHROMOSOME 17P13.1 DELETION SYNDROME	0.000545554	0.017820690121948424
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.017820690121948424
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.017820690121948424
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.017820690121948424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.017820690121948424
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.017820690121948424
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.017820690121948424
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.017820690121948424
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.017820690121948424
JOUBERT SYNDROME 21	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.017820690121948424
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.017820690121948424
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.017820690121948424
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.017820690121948424
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.017820690121948424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.017820690121948424
N SYNDROME	0.000545554	0.017820690121948424
STEEL SYNDROME; STLS	0.000545554	0.017820690121948424
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.017820690121948424
TYSHCHENKO SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.017820690121948424
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.017820690121948424
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.017820690121948424
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.017820690121948424
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.017820690121948424
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.017820690121948424
GERMAN SYNDROME	0.000545554	0.017820690121948424
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.017820690121948424
LATERAL MENINGOCELE SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.017820690121948424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.017820690121948424
COFFIN-SIRIS SYNDROME 7; CSS7	0.000545554	0.017820690121948424
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.017820690121948424
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.017820690121948424
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000545554	0.017820690121948424
CARDIOFACIOCUTANEOUS SYNDROME	0.000545554	0.017820690121948424
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.017820690121948424
AURICULOCONDYLAR SYNDROME	0.000545554	0.017820690121948424
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.017820690121948424
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000545554	0.017820690121948424
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.017820690121948424
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.017820690121948424
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.017820690121948424
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.017820690121948424
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.017820690121948424
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.017820690121948424
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.017820690121948424
CINCA SYNDROME	0.000545554	0.017820690121948424
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.017820690121948424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.017820690121948424
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.017820690121948424
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.017820690121948424
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.017820690121948424
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.017820690121948424
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.017820690121948424
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.017820690121948424
NOONAN SYNDROME 11; NS11	0.000545554	0.017820690121948424
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.017820690121948424
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.017820690121948424
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.017820690121948424
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.017820690121948424
TRANSALDOLASE DEFICIENCY	0.000545554	0.017820690121948424
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.017820690121948424
BAKER-GORDON SYNDROME; BAGOS	0.000545554	0.017820690121948424
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.017820690121948424
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.017820690121948424
CODAS SYNDROME	0.000545554	0.017820690121948424
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.017820690121948424
COLE-CARPENTER SYNDROME	0.000545554	0.017820690121948424
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.017820690121948424
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.017820690121948424
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.017820690121948424
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.017820690121948424
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.017820690121948424
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.017820690121948424
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.017820690121948424
EVEN-PLUS SYNDROME	0.000545554	0.017820690121948424
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.017820690121948424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.017820690121948424
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.000545554	0.017820690121948424
LAMB-SHAFFER SYNDROME	0.000545554	0.017820690121948424
DYSKERATOSIS CONGENITA	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.017820690121948424
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.017820690121948424
JOUBERT SYNDROME 26	0.000545554	0.017820690121948424
JOUBERT SYNDROME 25	0.000545554	0.017820690121948424
OCCIPITAL HORN SYNDROME	0.000545554	0.017820690121948424
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.017820690121948424
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.017820690121948424
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.017820690121948424
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.017820690121948424
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.017820690121948424
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.017820690121948424
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.017820690121948424
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.017820690121948424
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.017820690121948424
MECKEL SYNDROME 13; MKS13	0.000545554	0.017820690121948424
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.017820690121948424
RAHMAN SYNDROME	0.000545554	0.017820690121948424
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.017820690121948424
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.017820690121948424
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.017820690121948424
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.017820690121948424
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.017820690121948424
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.017820690121948424
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.000545554	0.017820690121948424
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.017820690121948424
TRISOMY 8Q	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.017820690121948424
DISTAL MONOSOMY 9P	0.000545554	0.017820690121948424
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.017820690121948424
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.017820690121948424
DEXTROCARDIA	0.000545554	0.017820690121948424
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.017820690121948424
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.017820690121948424
JOUBERT SYNDROME 28	0.000545554	0.017820690121948424
JOUBERT SYNDROME 27	0.000545554	0.017820690121948424
DISTAL TRISOMY 6P	0.000545554	0.017820690121948424
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.017820690121948424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.017820690121948424
OTOFACIOCERVICAL SYNDROME	0.000545554	0.017820690121948424
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.017820690121948424
SENIOR-LOKEN SYNDROME	0.000545554	0.017820690121948424
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.017820690121948424
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.017820690121948424
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000545554	0.017820690121948424
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.017820690121948424
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.017820690121948424
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.017820690121948424
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.017820690121948424
ABETAL34V AMYLOIDOSIS	0.000545554	0.017820690121948424
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.017820690121948424
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.017820690121948424
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.017820690121948424
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.017820690121948424
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.017820690121948424
JOUBERT SYNDROME 7	0.000545554	0.017820690121948424
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.017820690121948424
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.017820690121948424
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.017820690121948424
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.017820690121948424
FRIAS SYNDROME	0.000545554	0.017820690121948424
NOONAN SYNDROME 3; NS3	0.000545554	0.017820690121948424
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.017820690121948424
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.017820690121948424
NOONAN SYNDROME 5; NS5	0.000545554	0.017820690121948424
DE BARSY SYNDROME	0.000545554	0.017820690121948424
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.017820690121948424
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.017820690121948424
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.017820690121948424
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.017820690121948424
1P21.3 MICRODELETION SYNDROME	0.000545554	0.017820690121948424
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.017820690121948424
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.017820690121948424
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.017820690121948424
NOONAN SYNDROME 6; NS6	0.000545554	0.017820690121948424
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.017820690121948424
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.017820690121948424
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.017820690121948424
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.017820690121948424
JOUBERT SYNDROME 8	0.000545554	0.017820690121948424
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.017820690121948424
HEREDITARY OROTIC ACIDURIA	0.000545554	0.017820690121948424
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.017820690121948424
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.017820690121948424
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.017820690121948424
VASCULAR EHLERS-DANLOS SYNDROME	0.000545554	0.017820690121948424
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.017820690121948424
JOUBERT SYNDROME 2	0.000545554	0.017820690121948424
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.017820690121948424
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.017820690121948424
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.017820690121948424
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.017820690121948424
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.017820690121948424
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.017820690121948424
JOUBERT SYNDROME 6	0.000545554	0.017820690121948424
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.017820690121948424
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.017820690121948424
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.017820690121948424
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.000545554	0.017820690121948424
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.017820690121948424
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.000545554	0.017820690121948424
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.017820690121948424
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.017820690121948424
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.017820690121948424
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.017820690121948424
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.017820690121948424
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.017685619068204417
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.017685619068204417
KNOBLOCH SYNDROME	0.000541419	0.017685619068204417
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.017685619068204417
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.017685619068204417
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.017685619068204417
2Q24 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
SYSTEMIC SCLEROSIS	0.000541419	0.017685619068204417
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.017685619068204417
LUJO HEMORRHAGIC FEVER	0.000541419	0.017685619068204417
RIFT VALLEY FEVER	0.000541419	0.017685619068204417
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.017685619068204417
ROSAÏ-DORFMAN DISEASE	0.000541419	0.017685619068204417
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.017685619068204417
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.017685619068204417
EBOLA HEMORRHAGIC FEVER	0.000541419	0.017685619068204417
DYSOSTEOSCLEROSIS	0.000541419	0.017685619068204417
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.017685619068204417
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.017685619068204417
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.017685619068204417
AUTISM	0.000541419	0.017685619068204417
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.017685619068204417
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.017685619068204417
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.017685619068204417
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.017685619068204417
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.017685619068204417
GRISCELLI SYNDROME TYPE 2	0.000541419	0.017685619068204417
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.017685619068204417
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.017685619068204417
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.000541419	0.017685619068204417
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.017685619068204417
ASPARTYLGLUCOSAMINURIA	0.000541419	0.017685619068204417
CRISPONI SYNDROME	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.017685619068204417
CRYPTOCOCCOSIS	0.000541419	0.017685619068204417
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.017685619068204417
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.000541419	0.017685619068204417
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.017685619068204417
47,XYY SYNDROME	0.000541419	0.017685619068204417
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.017685619068204417
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.017685619068204417
EPILEPSY-TELANGIECTASIA	0.000541419	0.017685619068204417
SCLERODERMA	0.000541419	0.017685619068204417
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.017685619068204417
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.017685619068204417
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.017685619068204417
FRAGILE X SYNDROME	0.000541419	0.017685619068204417
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.017685619068204417
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.017685619068204417
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.017685619068204417
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.017685619068204417
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.017685619068204417
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.017685619068204417
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.017685619068204417
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.017685619068204417
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.017685619068204417
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.017685619068204417
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.017685619068204417
NOCARDIOSIS	0.000541419	0.017685619068204417
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.017685619068204417
CENTRAL DIABETES INSIPIDUS	0.000541419	0.017685619068204417
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.017685619068204417
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.017685619068204417
ADIPOSIS DOLOROSA	0.000541419	0.017685619068204417
FRONTAL ENCEPHALOCELE	0.000541419	0.017685619068204417
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.017685619068204417
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.017685619068204417
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.017685619068204417
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.017685619068204417
FETAL GAUCHER DISEASE	0.000541419	0.017685619068204417
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.017685619068204417
ADDISON DISEASE	0.000541419	0.017685619068204417
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.000541419	0.017685619068204417
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.017685619068204417
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.017685619068204417
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.017685619068204417
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.017685619068204417
ISOLATED SPINA BIFIDA	0.000541419	0.017685619068204417
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.017685619068204417
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.017685619068204417
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.017685619068204417
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.017685619068204417
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.017685619068204417
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.017685619068204417
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.017685619068204417
DIAMINOPENTANURIA	0.000541419	0.017685619068204417
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.017685619068204417
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.017685619068204417
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.017685619068204417
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.017685619068204417
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.017685619068204417
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.017685619068204417
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.017685619068204417
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.017685619068204417
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.000541419	0.017685619068204417
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.000541419	0.017685619068204417
GLIOBLASTOMA	0.000541419	0.017685619068204417
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.017685619068204417
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.017685619068204417
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.017685619068204417
STURGE-WEBER SYNDROME	0.000541419	0.017685619068204417
PFEIFFER SYNDROME TYPE 3	0.000541419	0.017685619068204417
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.017685619068204417
ROMANO-WARD SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.017685619068204417
FLYNN-AIRD SYNDROME	0.000541419	0.017685619068204417
ZIMMERMANN-LABAND SYNDROME 1	0.000541419	0.017685619068204417
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.017685619068204417
EPILEPSY, READING	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.017685619068204417
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.017685619068204417
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.017685619068204417
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.017685619068204417
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.017685619068204417
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.017685619068204417
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.017685619068204417
DARIER-WHITE DISEASE; DAR	0.000541419	0.017685619068204417
VIRAL HEMORRHAGIC FEVER	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.017685619068204417
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.017685619068204417
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.017685619068204417
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.017685619068204417
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.017685619068204417
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.017685619068204417
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.017685619068204417
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.017685619068204417
HUNTINGTON DISEASE; HD	0.000541419	0.017685619068204417
ADAMS-OLIVER SYNDROME	0.000541419	0.017685619068204417
ADRENOMYODYSTROPHY	0.000541419	0.017685619068204417
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.017685619068204417
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.017685619068204417
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.017685619068204417
CROUZON SYNDROME	0.000541419	0.017685619068204417
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.017685619068204417
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.017685619068204417
HADDAD SYNDROME	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.017685619068204417
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.017685619068204417
LASSA FEVER	0.000541419	0.017685619068204417
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.017685619068204417
SECONDARY SYRINGOMYELIA	0.000541419	0.017685619068204417
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.017685619068204417
2Q33.1 DELETION SYNDROME	0.000541419	0.017685619068204417
THYROCEREBRORENAL SYNDROME	0.000541419	0.017685619068204417
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.017685619068204417
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.017685619068204417
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.017685619068204417
1P36 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.017685619068204417
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.017685619068204417
TRISOMY 13	0.000541419	0.017685619068204417
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.017685619068204417
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.017685619068204417
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.017685619068204417
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.017685619068204417
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.017685619068204417
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.017685619068204417
PAPILLORENAL SYNDROME	0.000541419	0.017685619068204417
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.017685619068204417
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.017685619068204417
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.017685619068204417
TAKAYASU ARTERITIS	0.000541419	0.017685619068204417
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.017685619068204417
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.017685619068204417
DERMOTRICHIC SYNDROME	0.000541419	0.017685619068204417
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.017685619068204417
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.017685619068204417
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.017685619068204417
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.017685619068204417
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.017685619068204417
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.017685619068204417
STURGE-WEBER SYNDROME	0.000541419	0.017685619068204417
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.017685619068204417
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.017685619068204417
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.017685619068204417
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.017685619068204417
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.017685619068204417
CHIME SYNDROME	0.000541419	0.017685619068204417
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.017685619068204417
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.017685619068204417
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.017685619068204417
FOUNTAIN SYNDROME	0.000541419	0.017685619068204417
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.017685619068204417
GALACTOSIALIDOSIS	0.000541419	0.017685619068204417
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.017685619068204417
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.017685619068204417
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.017685619068204417
ALEXANDER DISEASE	0.000541419	0.017685619068204417
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.017685619068204417
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.017685619068204417
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.017685619068204417
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.017685619068204417
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.017685619068204417
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.017685619068204417
CRANIOSYNOSTOSIS 2	0.000541419	0.017685619068204417
RING CHROMOSOME 10 SYNDROME	0.000541419	0.017685619068204417
PORPHYRIA VARIEGATA	0.000541419	0.017685619068204417
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.017685619068204417
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.017685619068204417
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.017685619068204417
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.017685619068204417
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.017685619068204417
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.017685619068204417
7Q11.23 MICRODUPLICATION SYNDROME	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.017685619068204417
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.017685619068204417
BETA-MANNOSIDOSIS	0.000541419	0.017685619068204417
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.017685619068204417
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.017685619068204417
WHIPPLE DISEASE	0.000541419	0.017685619068204417
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.017685619068204417
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.017685619068204417
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.017685619068204417
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.017685619068204417
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.017685619068204417
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.017685619068204417
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.017685619068204417
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.017685619068204417
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.017685619068204417
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.017685619068204417
PARIETAL FORAMINA	0.000541419	0.017685619068204417
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.017685619068204417
COG8-CDG	0.000541419	0.017685619068204417
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.017685619068204417
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.017685619068204417
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.017685619068204417
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.017685619068204417
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.017685619068204417
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.017685619068204417
WOLFRAM SYNDROME	0.000541419	0.017685619068204417
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.017685619068204417
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.017685619068204417
FOUNTAIN SYNDROME	0.000541419	0.017685619068204417
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.017685619068204417
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.017685619068204417
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.017685619068204417
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.017685619068204417
HYPERPROLINEMIA TYPE 1	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.017685619068204417
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.017685619068204417
RAMON SYNDROME	0.000541419	0.017685619068204417
PINEOBLASTOMA	0.000541419	0.017685619068204417
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.017685619068204417
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.017685619068204417
LISSENCEPHALY 5; LIS5	0.000541419	0.017685619068204417
GITELMAN SYNDROME	0.000541419	0.017685619068204417
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.017685619068204417
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.017685619068204417
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.017685619068204417
MALAN OVERGROWTH SYNDROME	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.017685619068204417
MOYAMOYA DISEASE	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.017685619068204417
MOMO SYNDROME	0.000541419	0.017685619068204417
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.017685619068204417
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.017685619068204417
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.017685619068204417
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.017685619068204417
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.017685619068204417
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.017685619068204417
MICROSPORIDIOSIS	0.000541419	0.017685619068204417
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.017685619068204417
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.017685619068204417
LIPOID PROTEINOSIS	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.017685619068204417
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.017685619068204417
OCULOCEREBRORENAL SYNDROME OF LOWE	0.000541419	0.017685619068204417
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.017685619068204417
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.017685619068204417
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.017685619068204417
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.017685619068204417
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.017685619068204417
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.017685619068204417
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.017685619068204417
CITRULLINEMIA TYPE I	0.000541419	0.017685619068204417
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.017685619068204417
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.017685619068204417
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.017685619068204417
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.017685619068204417
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.017685619068204417
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
WHIM SYNDROME	0.000541419	0.017685619068204417
AICA-RIBOSIDURIA	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.017685619068204417
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.017685619068204417
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.017685619068204417
JUVENILE HUNTINGTON DISEASE	0.000541419	0.017685619068204417
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.017685619068204417
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.017685619068204417
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.017685619068204417
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.017685619068204417
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.017685619068204417
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.017685619068204417
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.017685619068204417
HHHH SYNDROME	0.000541419	0.017685619068204417
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.017685619068204417
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.017685619068204417
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.017685619068204417
CLARK-BARAITSER SYNDROME	0.000541419	0.017685619068204417
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.017685619068204417
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.017685619068204417
HYPOPHOSPHATASIA	0.000541419	0.017685619068204417
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.017685619068204417
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.017685619068204417
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.017685619068204417
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.017685619068204417
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.017685619068204417
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.017685619068204417
PGM3-CDG	0.000541419	0.017685619068204417
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.017685619068204417
IMMUNODEFICIENCY 47	0.000541419	0.017685619068204417
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.017685619068204417
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.017685619068204417
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.017685619068204417
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.017685619068204417
NASU-HAKOLA DISEASE	0.000541419	0.017685619068204417
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.017685619068204417
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.017685619068204417
NOONAN SYNDROME 7; NS7	0.000541419	0.017685619068204417
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.017685619068204417
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.017685619068204417
ATKIN-FLAITZ SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.017685619068204417
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.017685619068204417
16Q24.3 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.017685619068204417
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.017685619068204417
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.017685619068204417
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.017685619068204417
THYROCEREBRORETINAL SYNDROME	0.000541419	0.017685619068204417
THREONINEMIA	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.017685619068204417
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.017685619068204417
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.017685619068204417
TAY-SACHS DISEASE; TSD	0.000541419	0.017685619068204417
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.017685619068204417
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.017685619068204417
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.017685619068204417
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.017685619068204417
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.017685619068204417
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.017685619068204417
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.017685619068204417
FABRY DISEASE	0.000541419	0.017685619068204417
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.017685619068204417
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.017685619068204417
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.017685619068204417
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.017685619068204417
THANATOPHORIC DYSPLASIA	0.000541419	0.017685619068204417
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.017685619068204417
ADRENOLEUKODYSTROPHY	0.000541419	0.017685619068204417
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.017685619068204417
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.017685619068204417
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.017685619068204417
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.017685619068204417
SLC39A8-CDG	0.000541419	0.017685619068204417
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.017685619068204417
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.017685619068204417
NEURAMINIDASE DEFICIENCY	0.000541419	0.017685619068204417
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.000541419	0.017685619068204417
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.017685619068204417
HYPERPROLINEMIA, TYPE II	0.000541419	0.017685619068204417
EPISODIC ATAXIA TYPE 6	0.000541419	0.017685619068204417
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.000541419	0.017685619068204417
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.017685619068204417
HYPERLYSINEMIA, TYPE I	0.000541419	0.017685619068204417
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.017685619068204417
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.017685619068204417
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.017685619068204417
HYPER-BETA-ALANINEMIA	0.000541419	0.017685619068204417
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.017685619068204417
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.017685619068204417
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.000541419	0.017685619068204417
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.017685619068204417
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.017685619068204417
EPISODIC ATAXIA TYPE 3	0.000541419	0.017685619068204417
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.017685619068204417
PORPHYRIA	0.000541419	0.017685619068204417
PRADER-WILLI SYNDROME	0.000541419	0.017685619068204417
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.017685619068204417
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.017685619068204417
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.017685619068204417
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.017685619068204417
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.017685619068204417
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.017685619068204417
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.017685619068204417
HENNEKAM SYNDROME	0.000541419	0.017685619068204417
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.017685619068204417
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.017685619068204417
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.017685619068204417
RABIES	0.000541419	0.017685619068204417
DEND SYNDROME	0.000541419	0.017685619068204417
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.017685619068204417
ALG2-CDG	0.000541419	0.017685619068204417
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.017685619068204417
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.017685619068204417
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.017685619068204417
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.017685619068204417
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.017685619068204417
MPDU1-CDG	0.000541419	0.017685619068204417
GAPO SYNDROME; GAPOS	0.000541419	0.017685619068204417
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.017685619068204417
ALG9-CDG	0.000541419	0.017685619068204417
MOGS-CDG	0.000541419	0.017685619068204417
ACROCARDIOFACIAL SYNDROME	0.000541419	0.017685619068204417
FRYNS SYNDROME; FRNS	0.000541419	0.017685619068204417
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.017685619068204417
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.017685619068204417
BERNARD-SOULIER SYNDROME	0.000541419	0.017685619068204417
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.017685619068204417
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.017685619068204417
AYME-GRIPP SYNDROME; AYGRP	0.000541419	0.017685619068204417
GURRIERI SYNDROME	0.000541419	0.017685619068204417
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.017685619068204417
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.017685619068204417
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.000541419	0.017685619068204417
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.017685619068204417
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.017685619068204417
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.017685619068204417
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.017685619068204417
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.017685619068204417
HEREDITARY COPROPORPHYRIA	0.000541419	0.017685619068204417
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.017685619068204417
CRIGLER-NAJJAR SYNDROME	0.000541419	0.017685619068204417
POTOCKI-SHAFFER SYNDROME	0.000541419	0.017685619068204417
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.017685619068204417
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.017685619068204417
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.017685619068204417
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.017685619068204417
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.017685619068204417
NEUROFIBROMATOSIS TYPE 1	0.000541419	0.017685619068204417
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.017685619068204417
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.017685619068204417
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.017685619068204417
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.017685619068204417
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.017685619068204417
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.017685619068204417
PORENCEPHALY	0.000541419	0.017685619068204417
RECURRENT ACUTE PANCREATITIS	0.000541419	0.017685619068204417
PROLACTINOMA	0.000541419	0.017685619068204417
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.017685619068204417
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.017685619068204417
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.000541419	0.017685619068204417
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.017685619068204417
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.017685619068204417
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.000541419	0.017685619068204417
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.017685619068204417
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.017685619068204417
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.017685619068204417
RETT SYNDROME; RTT	0.000541419	0.017685619068204417
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.017685619068204417
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.017685619068204417
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.017685619068204417
MYASTHENIA GRAVIS	0.000541419	0.017685619068204417
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.017685619068204417
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.017685619068204417
EPISODIC ATAXIA, TYPE 6	0.000541419	0.017685619068204417
CRONKHITE-CANADA SYNDROME	0.000541419	0.017685619068204417
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.017685619068204417
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.017685619068204417
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.017685619068204417
LHERMITTE-DUCLOS DISEASE	0.000541419	0.017685619068204417
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.017685619068204417
ISOLATED BILIARY ATRESIA	0.000541419	0.017685619068204417
CONGENITAL HYDROCEPHALUS	0.000541419	0.017685619068204417
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.017685619068204417
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.017685619068204417
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.017685619068204417
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.017685619068204417
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.017685619068204417
RAMON SYNDROME	0.000541419	0.017685619068204417
FAMILIAL THROMBOCYTOSIS	0.000541419	0.017685619068204417
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.017685619068204417
KRABBE DISEASE	0.000541419	0.017685619068204417
KIFAFA SEIZURE DISORDER	0.000541419	0.017685619068204417
KEUTEL SYNDROME; KTLS	0.000541419	0.017685619068204417
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.017685619068204417
KAPUR-TORIELLO SYNDROME	0.000541419	0.017685619068204417
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.017685619068204417
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.017685619068204417
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.017685619068204417
ONDINE SYNDROME	0.000541419	0.017685619068204417
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.017685619068204417
CLASSIC HOMOCYSTINURIA	0.000541419	0.017685619068204417
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.017685619068204417
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.017685619068204417
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.017685619068204417
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.017685619068204417
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.017685619068204417
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.000541419	0.017685619068204417
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.017685619068204417
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.017685619068204417
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.017685619068204417
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.017685619068204417
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.017685619068204417
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.017685619068204417
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.017685619068204417
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.017685619068204417
